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ABSTRACT
Malaria  is  the  disease  caused  by  an  infection  of  a  mammalian  host  by  the  mosquito  borne
eukaryotic parasite Plasmodium. The associated morbidity and mortality are a major burden
on endemic regions and clearly related to poverty and instability. The symptoms of the disease
are diverse, ranging from fever and rigor in most patients to severe damage in solid organs such
as brain, lung, kidney and liver in a small fraction of the afflicted. Clinical symptoms of the
disease only occur when the parasite undergoes asexual replication within the red blood cells of
the host. Destruction of these cells and subsequent release of cytokines are responsible for the
recurring fever cycles of mild malaria. The mechanism underlying the occurrence of tissue
damage however, remain mostly elusive. The adhesion of infected red blood cells to the
endothelial wall of the microvasculature in the affected organs is a necessary requirement and
pathology is associated with the activation of specific immune cells residing within the blood
stream. Severity of disease is linked to extracellular accumulation of neutrophil proteins.
Neutrophils are abundant white blood cells, known to readily deploy an arsenal of weaponry
either by degranulation or by externalization of chromatin.
In this study we report a direct causal relationship between the active inflammatory neutrophil
cell death (NETosis) and the development of organ damage during a Plasmodium infection. We
show that NETs are released in circulation, digested by extracellular DNase and thereby supply
immune activation signals that drive inflammation. The systemic dissemination of these factors
leads to the release of cytokines, emergency granulopoiesis and upregulation of cellular
adhesion markers on endothelial cells thereby allowing for the binding of both infected red
blood cells and immune cells to the microvasculature of specific organs. Furthermore we supply
evidence, that repression of NETosis or inhibition of granulopoiesis abrogate these processes
and present promising therapeutic strategies.
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ZUSAMMENFASSUNG
Malaria ist die Erkrankung, die durch Infektion eines Säugetiers mit dem eukaryotischen
Parasiten Plasmodium entsteht. Die hiermit einhergehende Morbidität und Mortalität sind eine
enorme Belastung für die endemischen Gebiete und eindeutig mit Armut und Instabilität
derselben assoziiert. Die Symptome dieser Erkrankungen reichen von Fieber und
Gelenkschmerzen bis zu schweren Organschäden in Hirn, Lunge, Niere und Leber bei einem
geringen Teil der Erkrankten. Diese klinischen Symptome treten nur auf, während der Parasit
sich asexuell in roten Blutzellen vermehrt. Die Zerstörung von Erythrozyten und die daraus
resultierende Freisetzung von Zytokinen sind die Verursacher der malariatypischen
wiederkehrenden Fieberzyklen. Der Mechanismus, der zur Entstehung von Gewebsschäden
führt, ist hingegen nur unzureichend bekannt. „Eine notwendige Bedingung für das Auftreten
von Gewebeschäden ist, dass infizierte rote Blutzellen an das Endothel der Mikrovaskulatur bin.
Des Weiteren ist Organpathologie mit der Aktivierung bestimmter Immunzellen innerhalb des
Blutstroms korrelierbar. Die Schwere der Erkrankung ist direkt mit dem extrazellulären
Auftreten von Stoffen verbunden, die normalerweise von neutrophilen Granulozyten im
Zellinnern gespeichert werden. Neutrophile sind reichlich vorkommende weiße Blutzellen, die
dafür bekannt sind, ein ganzes Arsenal an Waffen bereitwillig durch Degranulierung oder
programmierten Zelltod einzusetzen.
In dieser Studie berichten wir von einem direkten kausalen Zusammenhang zwischen dem
aktiven inflammatorischen Zelltod (NETose) von Neutrophilen und der Entstehung von
Organschäden bei einer Plasmodium-Infektion. Wir zeigen, dass NETs in Zirkulation
freigesetzt und von extrazellulären DNase verdaut werden. Dadurch werden systemisch
Aktivierungssignale für eine weitere Immunantwort zur Verfügung gestellt und es kommt zur
Freisetzung von Zytokinen, Notfallgranulopoese und der Hochregulierung von zellulären
Adhäsionsmarkern auf Endothelzellen. Dies erlaubt das Binden von infizierten Erythrozyten
und Immunzellen an die Mikrovaskulatur bestimmter Organe. Wir zeigen außerdem, dass eine
Intervention mit der Entstehung von NETs oder der Freisetzung neuer Neutrophiler diesen
Prozess unterbindet und einen vielversprechenden therapeutischen Ansatz darstellt.
ABBREVIATIONS 3
ABBREVIATIONS
NE Neutrophil Elastase
WHO World Health Organization
DAMP Danger associated molecular pattern
PAMP Pathogen associated molecular pattern
DNA Deoxyribonucleic acid
Pr3 Proteinase 3
CG Cathepsin G
TLR Toll-like receptor
RBC Red blood cell
DV Digestive vacuole
PfEMP Plasmodium falciparum erythrocyte membrane protein
VCAM Vascular cell adhesion molecule
ICAM Intercellular adhesion molecule
EPCR Endothelial protein C receptor
IL Interleukin
TNF Tumor necrosis factor
IFN Interferon
CM Cerebral malaria
SMA Severe malarial anemia
GPI Glycosylphosphatidylinositol
G-CSF Granulocytes colony stimulating factor
CLR C-type lectin receptors
ROS Reactive oxygen species
NETs Neutrophil extracellular trap
MPO Myeloperoxidase
CGD Chronic granulomatous disease
CDK Cyclin dependent kinase
SVV Small Vessel Vasculitis
ANCA Anti-Neutrophil Cytoplasmic Antibodies
SLE Systemic lupus erythematosus
DC Dendritic cells
MMP Metalloproteinase
TF Tissue factor
4TFIP Tissue factor pathway inhibitor
APC Activated protein C
ELISA Enzyme linked immunosorbent assay
GBS Group b streptococcus
PKC Protein kinase C
MEK Mitogen-activated protein kinase kinase
ERK Extracellular signal activated kinase
PAD Peptidylargininedeaminase
CHOP C/EBP-homologous protein
IFA Immunofluorescence analysis
PMA Phorbol 12-myristate 13-acetate
LPS Lipopolysaccharide
AST Aspartate aminotransferase
ALT Alanine aminotransferase
WT Wild Type
BMM Bone marrow derived macrophages
GPCR G-protein coupled receptor
HO-1 Heme oxygenase 1
LTB4 Leukotriene B4
FCS Fetal calf serum
NSP Neutrophil serine protease
PBMCs Peripheral blood mononuclear cells
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INTRODUCTION
1. The parasite Plasmodium
Malaria is the disease resulting from infection of a mammalian host by parasites of the genus
Plasmodium. While malaria was once endemic even in southern Europe it is now restricted to
a broad band around the equator including wide areas in South America, Asia and Africa.
Malaria remains a devastating disease that is very clearly associated with poverty and has a
major negative impact on the economic, social and political stability of endemic regions.
Despite enormous efforts of humanitarian organizations such as the WHO and the Bill and
Melinda Gates foundation the number of newly infected cases remain in the hundreds of
millions (approximately 200 Mio. in 2017) each year, including up to 500.000 mortalities
annually (Varo, Crowley et al. 2018). The highest risk of severe disease remains with children
under the age of 15 years of age in sub-Saharan Africa. Pregnant women are also at very high
risk of disease and pregnancy associated malaria can lead to infant death as well as impaired
learning and cognitive abilities in children born from mothers infected with Plasmodium
falciparum.
1.1 The plasmodium parasite and its life cycle
Of the more than 200 described species of Plasmodium the five that cause human disease are
Plasmodium knowlesi, ovale, vivax, malariae and falciparum. The latter is responsible for the
majority of infections (~ 75%) and nearly all deaths associated with malaria. Plasmodia are
protists  –  a  unicellular  eukaryote  –  of  the  phylum  Apicomplexa.  These  parasites  display  a
complex life cycle in which a vertebrate host and a vector – mostly mosquitoes - are infected.
Plasmodium infects several different cell types, develops different morphologies and affects
different niches within the host (Fig. 1).
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1.1.1 Entry and infection of the liver
The infection of  a  mammalian host  by Plasmodium starts with the bite of a female infected
mosquito as it takes a blood meal. Prior to transmission the parasite resides in the salivary
glands of the mosquito and upon biting is injected into the wound along with the insect saliva
that prevents blood clotting. The sporozoites find a blood vessel and travel to the liver where
they establish a primary infection in hepatocytes. In this clinically silent liver stage the parasite
undergoes asexual replication and eventually thousands of merozoites are released into the
blood stream (Fig. 1).
1.1.2 The blood stage of Plasmodium
The merozoites released from the liver find and attach to red blood cells (RBCs). This initial
contact is mediated by a range of surface molecules including members of the major surface
protein (MSP) family, the reticulocytes binding protein homolog (PfRh) and PfAMA1 and leads
to invasion of the RBC. Throughout this process, the parasite sheds most of its surface receptors
and establishes the parasitophorous vacuole in which it grows under optimal conditions.
Astonishingly, the process of invasion takes only around 60 seconds and it is the only time
where parasites themselves are directly exposed to the immune system (Waldron 2015).
Once the parasite arrives within its niche it enters into young trophozoite stage which is also
referred to as the ring stage because of its morphology (Fig. 1). The parasite then continuously
grows within the infected red blood cell (iRBC) and eventually undergoes schizogonic division,
meaning that DNA replication occurs first and cellular segmentation only occurs when
merozoites are formed. In the case of P. falciparum this process takes 48 hours, whereas some
of the commonly used murine parasites such as Plasmodium chabaudi display a 24 hour cycle
(Brugat, Cunningham et al. 2014)
The parasite uses the main protein that is abundantly available in erythrocytes - hemoglobin -
as a food source eventually digesting up to 80 % of what used to be stored in the RBC. The
undigested hemoglobin is released into circulation as the RBC lyses. The breakdown of the
hemoglobin protein structure by parasite aspartic acid proteases leads to the release of free heme,
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which possesses an enormous redox potential and is therefore capable of generating oxygen
radicals such as hydroxyl and hydroperoxyl radicals. It is highly cytotoxic when not regulated
within the protein structure (Ferreira, Balla et al. 2008). The parasite detoxifies this prosthetic
group by transferring it into a waste management vacuole (digestive vacuole, DV) where it is
packaged into crystals called hemozoin and which is referred to as the malaria pigment
(Wunderlich, Rohrbach et al. 2012). Hemozoin is easily recognizable by its black color when it
accumulates in immune cells and organs of infected individuals.
Eventually 16 to 32 merozoites per iRBCs (Grüring, Heiber et al. 2011) are released into the
blood stream. While this process is poorly understood, it is hypothesized that a sudden increase
in intracellular pressure leads to the explosive lysis of the iRBCs which serves to disperse the
non-motile merozoites and ensure optimal reinfection of RBCs. This process also releases the
remaining contents of the iRBC and the parasitophorous vacuole, thereby providing ample
opportunity for the activation of surrounding immune cells.
Before returning to the vector, a small portion of the parasites undergo sexual development and
transform into male and female gametocytes, which can be taken up by a female mosquito
taking a blood meal from an infected mammalian host (Fig. 1).
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Figure 1: The lifecycle of plasmodium falciparummodified from (Rosenthal, 2008)
1.2 Modification of infected red blood cells
The parasite changes the iRBC drastically upon infection. Morphologically the once biconcave
and flexible cell loses its elasticity and adopts a parachute-like shape with protrusions on the
surface. These knobs on the surface serve the parasite to present a range of membrane-bound
INTRODUCTION 9
proteins and receptors. Most prominent among these is the erythrocyte membrane protein
family (PfEMP) (Chan, Fowkes et al. 2014), which mediates cell-cell contact between the iRBC
and other cells. Two important mechanism are mediated by these interactions. To mask their
presence from the immune system the iRBCs bind to uninfected RBCs, thus limiting the display
of foreign molecules and avoiding recognition and clearance of iRBCs in the blood stream.
Additionally, the PfEMP family mediates binding to endothelial adhesion markers such as
VCAM, ICAM-1, CD36 and endothelial protein C receptor (EPCR) (Kessler, Dankwa et al.
2017) thus allowing for the iRBC to cytoadhere to the endothelium of the blood vessels. In a
mechanism known as sequestration the parasite withdraws from the circulating blood stream
during the late stages of its intracellular replication where the changes to RBC morphology are
most drastic. By doing so the parasite avoids recognition and removal of misshaped RBCs by
splenic macrophages (Del Portillo, Ferrer et al. 2012).
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2. Malaria
2.1 Clinical manifestations of malaria
As mentioned above only the asexual blood stage of the parasite leads to clinical symptoms. The
classical symptom of malaria is paroxysm, or reoccurring coldness, rigor and fever. These
manifestations can be linked directly to the synchronous life cycle of the parasite. As the iRBCs
rupture – in the case of Plasmodium falciparum every 48 hours and in the case of the rodent
malaria Plasmodium chabaudi every 24 hours - both pathogen associated molecular patterns
(PAMPs) in the form of merozoites, digestive vacuoles and hemozoin as well as danger
associated molecular patters (DAMPs) in the form of undigested hemoglobin, free heme and
other remnants of the red blood cell are released into the blood stream (Schofield and Grau
2005).
The immune system recognizes the appearance of such stimuli and responds by producing
cytokines,  such  as  interleukin  (IL)  1,  IL  6  and  tumor  necrosis  factor  (TNF),  which  act  as
endogenous pyrogens. They diffuse to the hypothalamus and influence body temperature and
cause the fever cycles typically associated with malaria (Kwiatkowski 1990).
While that form of the disease is the most common some patients progress to severe disease,
meaning that damage occurs in the tissue of the organs. The syndromes of this form of malaria
can be discrete and overlapping and those afflicted can display single-organ or multi-organ
damage  and/or  failure.  The  most  life  threatening  of  these  are  cerebral  malaria  (CM),  acute
respiratory distress and severe malarial anemia (SMA). These manifestations mainly occur in
infants and small children in regions with high transmission (Schofield and Grau 2005). In
regions with lower transmission severe disease more frequently involves additional
disturbances such as renal failure, jaundice and pulmonary edema because primary infection
can occur in adulthood thus triggering distinct pathogenic mechanisms (Schofield, Novakovic
et al. 1996).
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The diversity of syndromes impedes the identification of unifying mechanisms of disease.
Nonetheless recent studies suggest a common scheme which requires an organ-specific
localization of iRBCs in target organs, the systemic and local recognition of PAMPs and DAMPs
and the subsequent production of proinflammatory cytokines eventually resulting in the
activation, recruitment and infiltration of inflammatory cells into the afflicted organs. Thus, the
occurring tissue damage is the end-stage manifestations of dysregulated inflammatory cascades
that are initiated in the target organs by PAMPs and DAMPs but are maintained by infiltrating
immune cells through positive feedback cycles (Schofield and Grau 2005).
Figure 2:Pathogenesis of malaria in several organs modified from Nature Reviews (Gazzinelli,
Kalantari et al. 2014)
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2.2 The Contribution of vascular occlusion to pathology
Historically severe malaria pathology was attributed to blockage of the microvasculature in
afflicted organs because of parasite sequestration and was thought to constitute an event like an
ischemic stroke. It was speculated that aggregates of infected and uninfected red blood cells
stuck to the endothelial cells walls in the deep vascular beds of the organs would lead to an
obstruction of blood flow and eventually rupture of the vessel (Miller, Baruch et al. 2002).
However the sequestration of the parasite is a complex mechanism that is influenced by more
cell types than just the infected red blood cell and the endothelium (Alencar Filho, Lacerda et
al. 2014). Evidence began to emerge demonstrating an important role for immune cells in the
development of severe malaria pathology.
2.3 The complex mechanism of parasite sequestration
Parasite sequestration to specific organs is the first requirement and starting event of
pathological mechanisms. The parasite changes the shape of the infected erythrocyte quite
drastically, especially towards the later stages of its replication cycle, and the iRBCs therefore
need to avoid recognition and clearance by splenic macrophages. The family of proteins mostly
responsible for this interaction is the infamous erythrocyte membrane protein 1 (PfEMP1) that
mediates binding to ICAM1, VCAM1, CD31, CD36 and EPCR, and is thus responsible for
binding of the parasitized red blood cells to the endothelium of microcapillaries (de Koning-
Ward, Dixon et al. 2016). While this strategy is advantageous for the parasite in that it allows
avoidance of the spleen it has the pathological effect of concentrating the parasite in various
target organs. This also increases the local concentration of both PAMPs and DAMPs associated
with the Plasmodium infection and thus potentially creates effects more adverse than the
situation in the larger vasculature (Schofield and Grau 2005).
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2.4 Immunostimulatory products of parasite growth
The parasite produces a variety of bioactive molecules that can potentially induce an immune
response especially when reaching high local concentration due to organ specific sequestration
patters. Among these is the glycosylphosphatidylinositol (GPI) of Plasmodium spp. Purified
GPI induces the expression of various molecules that play a major immunostimulatory role
such as TNF, IL1α and IL12, inducible nitric-oxide synthase and importantly the
aforementioned endothelial adhesion molecules (Autino, Corbett et al. 2012).
The bioactivity of the parasite pigment hemozoin is less well defined, with some reports
showing induction (Coban, Ishii et al. 2002) or inhibition (Skorokhod, Alessio et al. 2004) of
dendritic cell maturation. In general, hemozoin seems to have immunosuppressive effects
(Schofield and Grau 2005) although some publications claim that by itself it is chemically and
immunologically inert (Boura, Frita et al. 2013). These studies suggest that hemozoin can serve
as a scaffold or carrier, which binds other immunostimulatory agents such as parasite DNA and
transports and presents them to immune cells thus activating for example TLR9 (Coban, Ishii
et al. 2005, Kalantari, DeOliveira et al. 2014). Additionally, hemozoin can activate the NOD-
like  receptor  containing  pyrin  domain  3  (NLRP3)  inflammasome  complex  and  lead  to  the
release of IL1β (Autino, Corbett et al. 2012, Olivier, Van Den Ham et al. 2014)
The effects and recognition of both infected red blood cells and free parasites in the blood
stream is even less well understood. Splenic macrophages and monocytes respond to those
iRBCs that have not sequestered by release of cytokines (Del Portillo, Ferrer et al. 2012) but
literature in general is surprisingly sparse. One possible explanation is the reduced
immunological control that red blood cells experience in general – they do not express MHC
molecules – suggesting that the parasite is hidden from the immune system in the niche it has
chosen (Gupta 2005). Additionally, the extracellular episode of the parasite is so short that is
might just not suffice for proper immune recognition.
A long-ignored player in the game of malaria pathology is free heme released from the
undigested hemoglobin still present in the dying red blood cell as the parasite lyses its former
host. In addition, acute malaria infections induce hemolysis of uninfected red blood cells, which
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adds  to  accumulation  of  free  heme  in  circulation  (Jakeman,  Saul  et  al.  1999).  Heme  is  a
prosthetic group of many different enzymes such as hemoglobin but is mainly known for its
extreme redox potential, requiring the structure to be tightly controlled within a protein
scaffold. Lacking target specificity, heme generates free oxygen radicals and thus develops a
cytotoxic capacity (Fig. 3).
Systemic release of heme has been hypothesized to activate neutrophils in particular (Chen,
Zhang et al. 2014) as they are the most abundant white blood cell in circulation and will
therefore be the first cell to be confronted by such systemically released danger molecules.
Figure 3: Mechanisms of heme release and detoxification. During Plasmodium infection
Haptoglobin (Hp) is depleted leading to inadequate clearance of cell free ferric hemoglobin
(HbFe3+). This in turn leads to the release of heme into the blood stream. Heme can be
scavenged by Hemopexin (Hpx), Albumin or Heme Oxygenase-1 (HO-1). From (Ferreira, Balla
et al. 2008).
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3. Neutrophils in health and disease
The neutrophil is one of the most abundant immune cell in circulation of mammalian hosts
and was long hypothesized to be the primitive foot soldier of the immune system, making up
20- 70 percent of the circulating white blood cells depending on the species. They develop in
the bone marrow from precursor cells and are terminally differentiated when they enter the
blood  stream (Amulic,  Cazalet  et  al.  2012).  The  recruitment  of  neutrophils  out  of  the  bone
marrow relies on the cytokine granulocytes colony stimulating factor (G-CSF). Neutrophils are
short lived and therefore have a high turn-over at homeostatic conditions but increased release
of G-CSF can induce emergency granulopoiesis. Neutrophils already carry most of the arsenal
of highly active molecules that they deploy when a threat is recognized, but to prevent harm
these are stored in inactive forms in membrane-bound organelles called granules. Neutrophils
express a variety of cytokine and pattern recognition receptors including all TLRs except TLR3,
C-type lectin receptors (CLRs), and antibody and complement receptors enabling them to
recognize cytokines and many DAMPs emanating from a site of infection. Such signals induce
extravasation out of the blood stream and into the underlying tissue where the neutrophils
travel along the chemotactic gradient until they meet the focus of infection. Sufficiently
activated by the local inflammatory milieu they perform their many antimicrobial and
inflammatory functions (Amulic, Cazalet et al. 2012, Kolaczkowska and Kubes 2013, Mayadas,
Cullere et al. 2014).
Neutrophils are short-lived cells compared to other effector cells of the immune system. They
go into apoptosis after a short aging period which serves to limit the collateral tissue damage
caused by their destructive inflammatory functions (Harbort, Soeiro-Pereira et al. 2015). These
neutrophil effector mechanisms must be tightly controlled to establish a balance between pro-
inflammatory and anti-inflammatory signals, between the right amount of destruction
unleashed to kill potential threats and control of this destruction to not damage the self.
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3.1 Neutrophil effector functions
Once neutrophils reach their destination they activate various components of their arsenal to
combat the infectious agent. Neutrophils produce proinflammatory cytokines to recruit
additional immune cells and contribute to microbial clearance through degranulation,
production of reactive oxygen species (ROS) and formation of neutrophil extracellular traps
(NETs) (Fig.4). These mighty antimicrobials are however indiscriminate in their destructive
potential, destroying microbes and host tissue alike (Amulic, Cazalet et al. 2012).
Figure 4: Neutrophils are recruited to sites of inflammation where they carry out their effector functions, figure
modified from (Amulic, Cazalet et al. 2012)
3.1.1 Degranulation and phagocytosis
Neutrophils possess a specialized storage organelle – called granule - which serves to store their
antimicrobial repertoire in an inactive state until it needs to be released. These are (a) proteases
such as neutrophil elastase (NE) and proteinase 3 (Pr3), which can cleave both virulence factors
and extracellular matrix proteins, (b) cationic peptides able to form pores in the membrane of
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cells and leading to permeabilization, (c) nutrient-binding proteins which sequester and
remove essential nutrients and (d) enzymes that mediate the production of ROS. As the
neutrophil is activated, these granules can be mobilized in various ways, bringing their weapons
to bear. Fusion of the granular membrane with the plasma membrane of the cell results in
degranulation, expelling the content of the vesicle into the extracellular space (Amulic, Cazalet
et al. 2012). Thus liberated the antimicrobial substances can carry out their destined functions
killing microbes but also activating other immune cells and damaging the surrounding tissue
(Wang 2018)
 A less destructive mechanism is the engulfing of microorganisms that the neutrophil
encounters by phagocytosis. The microbe is kept in a phagosome and the granules are fused
with this structure, which creates a phagolysosome. In this newly created killing space the
content of the granules create extremely harsh conditions which serve to destroy the captured
foe (Amulic, Cazalet et al. 2012).
3.1.2 The oxidative burst
Apart from the pregenerated and ready to deploy weaponry that neutrophils store in their
granules they can also activate the production of ROS – another potential class of antimicrobials.
The generation of these molecules require the activity of the NADPH oxidase, a multimeric
enzyme complex that assembles in both the phagosomal and the plasma membranes to reduce
molecular oxygen to highly active superoxide (Harbort, Soeiro-Pereira et al. 2015). This radical
can be further processed into other species by subsequent enzymatic changes. ROS modify and
damage molecules including DNA, proteins and lipids by oxidation. As described for other
effector functions of the neutrophil before ROS too are indiscriminate of their target, destroying
invading pathogen and bystander host cells alike. In addition to killing microbes in the
phagolysosome, ROS have important signaling functions, including in control of NET
formation (Harbort, Soeiro-Pereira et al. 2015).
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3.1.3 Neutrophil extracellular traps
In a final commitment, the neutrophil can activate a cellular program leading to its own death
and the expulsion of a neutrophil extracellular trap (NETs). During this active inflammatory
cell death, the neutrophil breaks down the granule membrane in the cytoplasm allowing the
enzymes NE and myeloperoxidase (MPO) to reach the nucleus (Papayannopoulos, Metzler et
al. 2010). This leads to the decondensation of the chromatin structure and eventually a web-like
structure of chromatin decorated with the content of the former granules is released
(Brinkmann, Reichard et al. 2004) (Fig. 5). NETosis is an active mechanism, which can be
engaged by a variety of stimuli and requires intracellular signaling cascades.
Figure 5: Neutrophil extracellular trap generated in vitro and documented by electron microscopy, image
courtesy of Volker Brinkmann. Red arrows indicate web-like chromatin structures
3.1.3.1 Diverse stimuli lead to NET induction
A wide range of both biological and chemical stimuli induce NETosis in primary human
neutrophils. The first description of NETosis was in response to the mitogenic activator of
protein kinase C phorbol myristate acetate (PMA) (Brinkmann, Reichard et al. 2004) which is
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still widely used as the positive control. The pathway leading to PMA induced NETs is thus the
best characterized. Amulic et al demonstrated that other mitogenic signals such as
Concanavalin A (ConA) and phytohaemagglutinin, two plant lectins commonly used to induce
proliferation of lymphocytes, also induce NETosis.
Other described stimuli include biological more relevant agents such as group B streptococcus
(GBS), the hyphae of the fungus Candida albicans, free extracellular heme (Chen, Zhang et al.
2014), the calcium ionophore A23187 produced by Streptomyces chartreusensis and  the
potassium ionophore nigericin from Streptomyces hygroscopicus (Kenny, Herzig et al. 2017).
3.1.3.2 Mechanism of NET formation
NET formation in response to these diverse stimuli leads to the same web-like structures of
extracellular chromatin decorated with the antimicrobials from the granules. The pathway and
subcellular requirements differ slightly between different stimuli.
PMA, C. albicans and GBS activate PKC and subsequently the Raf/MEK/ERK signaling
pathway which eventually leads to the phosphorylation and activation of the NADPH oxidase.
The production of ROS by NOX2 is a requirement of PMA induced NETosis (Kenny, Herzig
et al. 2017). Interestingly, complete scavenging of ROS can impair C. albicans induced NET
formation but the lack of NADPH oxidase activity – as assessed by working with cells from
patients suffering from chronic granulomatous disease (CGD) – is not required. GBS seems to
induce NETosis completely independently of ROS, as the scavenger pyrocatechol fails to inhibit
GBS-induced NETs.
Metzler et al showed an important role for MPO during the generation of PMA induced NETs,
which has been confirmed for the generation of NETs by both C. albicans and GBS (Kenny,
Herzig et al. 2017). In the same publication the researches demonstrated an essential role for
NE and PR3. These enzymes are stored together with another proteinase called cathepsin G
(CG) in the azurophilic granules of the neutrophil. Upon activation of the cell the granules are
permeabilized and NE – and potentially Pr3 and CG – travel to the nucleus. NE enters the
nucleus  and  mediates  the  essential  chromatin  decondensation  by  cleavage  of  histones  that
eventually leads to the release of NETs (Papayannopoulos, Metzler et al. 2010).
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This event coincides with nuclear envelope breakdown, which leads to mixing of cytoplasmic
and nuclear components. Eventually the plasma membrane of the cell is also broken down and
the NET is released into the extracellular space (Papayannopoulos, Metzler et al. 2010, Kenny,
Herzig et al. 2017). Mitogenic signaling is required for NOX2 activation, but also leads to partial
cell cycle restart and activation of cyclin dependent kinase 6 (CDK6). CDK6 is required for NET
formation but the exact targets of this kinase remain uncharacterized (Amulic, Knackstedt et al.
2017). Importantly, cellular processes that are canonically regulated by CDK6, such as
transcription and microtubule polarization, are not involved in the mechanism of NETs.
Interestingly the proteases that initially facilitate the production of NETs, NE and Pr3, remain
active and bound to the released structure and carry out important immune modulatory and
cytotoxic functions (Kaplan and Radic 2012). It is likely that the production of NETs at least
partly serves the purpose of creating high extracellular concentrations of these proteases
without allowing their dissemination as would happen if they were released by degranulation.
Figure 6: Mechanism of neutrophil extracellular tap formation, figure modified from (Ref Brinkman 2012)
3.1.3.3 The histone citrullination controversy
During transcription, chromatin relaxation can be achieved by post-translational modification
of histones. The deimination of positively charged arginine side chains to the neutral and polar
citrulline by the peptidylargininedeaminase 4 (PAD4) is such a modification. Several studies
have implicated PAD4 activity (Lewis, Liddle et al. 2015) to be crucial for LPS induced NET
formation in murine neutrophils and the neutrophil cell line HL-60. Many labs, including ours,
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also observe histone citrullination in response to various stimuli, however inhibition of this
process by small molecule chemical inhibitors does not influence NET formation. The role of
PAD4 in NET formation therefore remains controversial. This dissertation includes
experiments to genetically test its involvement in NETosis.
3.2 NETs in health and disease
The release of NETs is a defense mechanism aimed at ensuring local confinement of pathogens.
Additionally, NETs are immunostimulatory and control coagulation (Khandpur, Carmona-
Rivera et al. 2013, McDonald, Davis et al. 2017). Both NETosis and degranulation are most
likely relevant after extravasation into the tissue or on mucosal surfaces where the released
substances only have a limited capacity to spread. Activation of such mechanisms in the blood
stream might be less associated with pathogen clearance but may have roles in systemic immune
activation.
3.2.1 NETs fight infection in vivo
Defining the in vivo role of NETs during an infection has not been easy mainly due to the lack
of a defined NET deficient mouse, although there are several potential candidates including a
PAD4 -/-, a NE or NE/Pr3 -/- , a Nox2 -/- and a CDK6 -/- mouse .
While the potential of NETs to kill pathogens, such as E. coli, in vitro is well established (Kenny,
Herzig et al. 2017) the importance of NETs in vivo is less clear and most evidence remains
indirect. After undergoing gene therapy a CGD patient was able to clear a persistent Aspergillus
infection. The patient’s neutrophils showed restored NADPH oxidase activity, NET formation
and NET mediated killing of Aspergillus ex vivo (Bianchi, Hakkim et al. 2009).
More recently the group of Paul Kubes demonstrated a beneficial role of NETs formed in the
liver microvasculature of E. coli infected mice. These NETs ensnared bacteria in the liver and
prevented systemic dissemination of the pathogen. Both depletion of neutrophils by antibody
injection and administration of DNase 1 reduced the amount of trapped bacteria (McDonald,
Urrutia et al. 2012).
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Moreover bacteria that express DNases as virulence factors disseminate more easily in the host,
potentially by avoiding entrapment by NETs (Beiter, Wartha et al. 2006, Buchanan, Simpson et
al. 2006).
3.2.2 NETs can be detrimental to the host
Unfortunately, excessive or systemic NET formation and impaired degradation of NETs are
associated with exacerbated immune responses and can lead to tissue injury (Liu, Su et al. 2016)
and unwanted coagulation and thrombus formation (Kaplan and Radic 2012). Interestingly,
this effect has been described both in non-infectious autoimmune as well as in infectious
settings, some of which are described below.
3.2.3 NETs and vasculitis
Vasculitis is an umbrella-term for a group of chronic diseases caused by the inflammation of
blood vessels that can be accompanied by necrotic cell death. Neutrophils play a detrimental
role in a subset of these diseases called Small Vessel Vasculitis (SVV) which is characterized by
damage occurring in the small vessels and highly associated with the occurrence of
autoantibodies directed against proteins that can be found in the neutrophil cytoplasm
(Soderberg and Segelmark 2016). Anti-Neutrophil Cytoplasmic Antibodies (ANCA) are by
large directed against Pr3 and MPO. Interestingly, exposure of neutrophils to ANCA leads to
production of ROS as well as degranulation while TNF primed neutrophils respond to ANCA
by undergoing NETosis (Kessenbrock, Krumbholz et al. 2009). Furthermore, neutrophils
isolated from patients with SVV spontaneously undergoing NETosis in vitro. Further evidence
for the involvement of NETs in the pathogenesis of SVV is provided by the observation that
NET related histones cause vascular necrosis in severe glomerulonephritis – a major
complication associated with SVV (Kumar, Kulkarni et al. 2015).
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3.2.4 NETs and systemic lupus erythematosus
NETs  and  apoptotic  neutrophils  are  normally  cleared  out  of  circulation  by  phagocytes  and
extracellular enzymes such as DNase 1 (Ren, Tang et al. 2003), as they otherwise provide ample
material to induce autoantibodies. Neutrophil cell death is most certainly not the only potential
source of autoantigens but it appears to be an important one. Interestingly, the mechanism by
which NETs reach the germinal centers and participate in antibody-dependent autoimmunity
is not fully understood.
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by an
overproduction of such autoantibodies directed against dsDNA and chromatin as well as NET-
related autoantigens such as MPO, Pr3 and NE (Molnar, Kovacs et al. 2002). These antibodies
are thought to be largely responsible for tissue damage observed in patients suffering from flares
of disease. This is due to the formation of immune complexes, which, for example, can bind to
the glomerular capillaries of the kidney directly inducing necrotic cell death of endothelial cells
(Hirose,  Itabashi  et  al.  2017).  Nephritis  is  a  major  symptom  of  lupus  ranging  from   mild
proteinuria to acute kidney failure (Anders and Vielhauer 2011).
Inhibition of DNase1 activity can occur due to both the accumulation of inhibitors such as g-
actin and the protection of NETs from degradation by bound antibodies (Hakkim, Furnrohr et
al. 2010). In accordance, earlier findings show that mutations and polymorphism in DNase 1
are associated with SLE (Yasutomo, Horiuchi et al. 2001, Bodano, Gonzalez et al. 2006). The
disease can also very clearly be associated with the presence of type I interferons and they seem
to play a crucial role in pathogenesis (Hooks, Moutsopoulos et al. 1979) by sustaining a
peripheral inflammatory milieu. Interestingly and concurring with the situation describe for
SVV, the groups of Lange and Garcia-Romo et al described NETs as a potent inducer of type I
interferon release by pDCs, thus underlining the significance of NETs in the pathogenesis of
this autoimmune disease.
INTRODUCTION 24
3.2.5 NETs and sepsis
In sepsis, a bacterial or fungal infection reaches the blood stream and induces hyper
inflammation, characterized by massive induction of circulating cytokines. In this setting,
platelets get activated by Toll Like Receptor (TLR) 4 mediated recognition of bacterial
compounds, bind to neutrophils and induce rapid NET formation in circulation. While this
might lead to some clearance of bacteria it mainly induces damage to endothelial cells and
propagates an escalating immune response (Caudrillier, Kessenbrock et al. 2012). The
pathogenesis of sepsis is largely dependent on extracellular histones (Xu, Zhang et al. 2009)
which supports the correlation between sepsis and both SLE and vasculitis. Unlike in the two
autoimmune diseases however, the pathogenesis of sepsis does not rely on the generation of
antibodies but on other adverse effects described for NETs such as direct destruction of the
endothelial lining as well as induction of pDCs. Indeed, septic mice display circulating NET
components  such  as  free  histones  (Xu,  Zhang  et  al.  2009)  and  MPO and  their  neutrophils
undergo NETosis more readily in vitro. Interestingly the same report shows detrimental effects
of DNase 1 administration in their model, suggesting an adverse role for liberation of NET
components in circulation by extracellular digestion (Meng, Paunel-Gorgulu et al. 2012).
3.2.6 NET components directly induce endothelial damage
A reoccurring theme in all of the above listed diseases is that individual components of NETs
seem to be capable of inducing endothelial damage. Indeed, two independent studies described
direct effects of NETs on both the endothelium and the epithelium. NETs can be induced by
activated endothelial cells (Gupta, Joshi et al. 2010) but then they in turn appear to induce cell
death programs in the endothelium directly leading to endothelial leakage and barrier
dysfunction (Saffarzadeh, Juenemann et al. 2012). This effect seems to be mainly mediated by
histones as treatment of the NETs with anti-histone antibodies prior to challenging the
endothelial cells abrogated the induction of cell death.
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However, histones are not the only molecule associated with NETs that has been described to
induce adverse effects in endothelial cells. Grechowa et al show that human neutrophil elastase
can directly induce endothelial cell death by induction of C/EBP-homologous protein (CHOP).
Additionally NE and Pr3 can directly induce apoptosis in endothelial cells by direct cleavage of
the transcription factor NF-kappaB (Preston, Zarella et al. 2002, Pendergraft, Rudolph et al.
2004). Taken together these reports suggest that systemic release of NETs promotes endothelial
cell death, leakage and barrier dysfunction.
3.2.7 NETs and thrombosis
When blood vessels are injured it is of utmost importance that the organism seals these breaks
quickly, so that damage to the tissue and excessive bleeding can be prevented. Thrombi or blood
clots are formed by platelet aggregation and activation and can lead to red blood cell
accumulation in a fibrous matrix. This process is immensely advantageous as it prevents the
loss of crucial blood volume but must, on the other hand, be extremely tightly controlled. Blood
needs to flow in both large and small vessels in order to guarantee a constant supply of oxygen
to the tissues. Blockage of blood vessels by dysregulated thrombus formation can lead to vessel
rupture, blood leakage and eventually loss of oxygen supply causing the underlying tissue to die
(Deb, Sharma et al. 2010).
NETs generated in circulation can trap platelets and red blood cells and thereby serve as a
scaffold for thrombus formation in vitro and in vivo. Accordingly, experimental generation of
thrombi in a primate model revealed extracellular DNA as a backbone of the clump (Fuchs,
Brill et al. 2010) Additionally, NE present on NETs in high concentrations can cleave and
inactivate tissue factor pathway inhibitor (TFPI) leading to increased procoagulant activity
(Massberg, Grahl et al. 2010). Moreover tissue factor (TF) itself is deposited onto the NETs thus
further increasing their procoagulant capacity (von Bruhl, Stark et al. 2012). This mechanism
of NET induced coagulation and thrombus formation shows, as was observed before, signs of
self-propagation. Procoagulant activity induces platelet activation and those activated platelets
can then trigger NETosis again (Clark, Ma et al. 2007).
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NETs are therefore implicated in the pathogenesis of deep vein thrombosis (Brill, Fuchs et al.
2012) and ischemic stroke (Laridan, Denorme et al. 2017) because they can lead to a
dysregulation of the coagulation cascade and hence induce vascular obstruction and eventually
rupture.
3.3. Neutrophils and malaria
Neutrophils constantly patrol the blood stream, the compartment where Plasmodium infection
takes place and where parasites can often reach high densities of more than 250,000 iRBCs per
µl. It is therefore very likely that neutrophils are involved in either resolution or progression of
disease. Interestingly, people from malaria endemic regions such as people of African descent
and some ethnic groups from the Middle East display low basal neutrophil counts (benign
neutropenia). Malaria has exerted an enormous evolutionary selective pressure on populations
living in such endemic areas and has selected for gene variants that promote tolerance.
Decreased neutrophil counts could therefore indicate a detrimental role for neutrophils in
malaria infections. Moreover neutrophilia is very commonly observed in patients suffering
from both P. falciparum and P. vivax malaria (Maina, Walsh et al. 2010, Olliaro, Djimde et al.
2011, Kotepui, Piwkham et al. 2015) and is associated with disease severity.
Indeed, two reports suggest that neutrophils might play a detrimental role in the development
of severe malaria (Chen, Zhang et al. 2000, Rocha, Marques et al. 2015) although the older one
uses an outdated antibody for the depletion of neutrophils that has in the meantime been shown
not to be specific for neutrophils. Another publication implicates NETs in pathogenesis of acute
respiratory distress in a P. berghei model (Sercundes, Ortolan et al. 2016). The authors
successfully treat disease employing the same strategies commonly used in patients with cystic
fibrosis (NE inhibitors and active DNase, both applied by inhalation).
In patients a recent transcriptomic analysis that compared blood from severe and
uncomplicated P. falciparum malaria patients identified a G-CSF-induced neutrophil
granulopoiesis signature as a specific feature of cerebral malaria. Interestingly the highest log-
fold upregulation between severe and uncomplicated malaria was apparent in genes encoding
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neutrophil granule proteins such as NE and metalloproteinase-8 (MMP-8). In accordance with
this observation children with retinopathy-positive cerebral malaria display an accumulation of
externalized neutrophil proteins such as NE, Pr3 and MPO (Feintuch, Saidi et al. 2016).
In addition to the accumulation of neutrophil granule components, complicated malaria is
associated with increased cell-free nucleosomes in circulation, which are partly host derived.
NETs  are  an  important  platform  for  the  externalization  of  both  chromatin  and  neutrophil
proteases. Initial reports have indicated the presence of NETs in both human patients (Baker,
Imade et al. 2008) and mouse infections (Sercundes, Ortolan et al. 2016).
INTRODUCTION 28
4. Aim of the study
Many of the neutrophil antimicrobials are indiscriminate in their killing capacity and can
induce collateral damage by destruction of host cells. While this trade-off can be beneficial when
occurring in spatially confined compartments it becomes detrimental when occurring
systemically. Neutrophil components and specifically NETs are pathogenic in autoimmune
diseases such as SLE and SVV and infectious diseases such as sepsis. These diseases seem rather
different at first glance but are tied together by the common theme of systemic NET release. A
Plasmodium infection represents another condition that can induce such systemic release of
neutrophil components. While there already have been initial reports of neutrophil
involvement in the pathogenesis of malaria a conclusive analysis of the effects of systemic NET
release during Plasmodium infection is still missing.
The aim of this study was to investigate the function of NETs in the context of human and
rodent  malaria,  to  define  their  mode  of  action  and  to  determine  whether  they  represent  a
potential new therapeutic target.
We therefore set out to test whether NETs are present in the circulation of human patients and
if so what other parameters correlate with the amount of extracellular NET components.
We addressed the mechanisms of NET formation induced by potential malaria associated
stimuli. The insights into the requirements of malaria PAMP or DAMP induced NET formation
would then allow us to transition to a mouse malaria model infect the proper NET deficient
genotype and analyze neutrophil pathogenic mechanisms in vivo.
We thus aimed to determine mechanistically what systemic and local changes are induced by
malaria associated NET formation and to thereby identify potential targets of intervention for
novel adjunctive therapies.
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RESULTS
5. Malaria leads to NET induction via heme and TNF
5.1 NETs are present in the circulation of malaria patients
Malaria is associated with accumulation of circulating NET components such as NE, Pr3, MPO
and nucleosomes. Furthermore, levels of these proteins are correlated with the severity of a P.
falciparum infection (Feintuch, Saidi et al. 2016). However, NETs themselves have so far not
been clearly identified in the circulation of infected individuals (Baker, Imade et al. 2008) and
it  remains  unknown  if  the  above  mentioned  granule  proteins  are  released  via  NETs  or  by
degranulation. To analyze NET production in malaria patients we conducted a field study at
the Albert Schweitzer Hospital in Lambaréné in Gabon. The province of Moyen Ogoove is
endemic for malaria, there is year round transmission which peaks during wet seasons. The
region is mainly afflicted by P. falciparum, but P. malariae and P. ovale can also be observed
(Scherbaum, Kosters et al. 2014).
We recruited patients of both sexes at the ages between 1.5 – 84 years, who were confirmed to
be infected with P. falciparum by the diagnostic laboratory by Giemsa thick smear analysis. As
a control, we also recruited healthy individuals in a similar age range that were confirmed to be
P. falciparum negative also by thick blood smear analysis. We determined NETs by sandwich
ELISA as complexes of the granule protein NE and DNA in the plasma of these patients. The
components are normally separated in intact neutrophils but they co-localize on NETs. We
observed that a significant proportion of patients had NET complexes in their plasma (Fig. 7
A).
While the parasite lives in the red blood cells it uses hemoglobin as its source of nutrition.
Leftover hemoglobin is released into the blood stream. Additional hemoglobin is released by
the lysis of uninfected bystander cells. Extracellular hemoglobin releases its prosthetic group
heme which can therefore serve as a marker for hemolysis occurring during a malaria infection.
A previous study proposed extracellular heme as an inducer of NETs in sickle cell disease (Chen,
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Zhang et al. 2014), which although not an infectious is also a hemolytic disease. Therefore we
determined the concentration of heme in the patient samples (Fig 7 C) and, as expected,
observed a significant increase when compared to healthy individuals. Interestingly, the amount
of heme can be positively correlated with the presence of NETs in the circulation (Fig 7 B).
When this analysis is restricted to the patients who display NET levels above those of the healthy
control only (responders) (Fig. 7 D) this correlation becomes even more pronounced,
suggesting a direct link between hemolysis and intravascular NET formation.
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Figure 7: P. falciparum infection induces accumulation of extracellular NETs and free heme
Plasma was isolated from patients suffering from malaria and healthy individuals and subsequently analyzed by
sandwich ELISA for NE/DNA complexes (A). The concentration of extracellular heme was determined from the
same samples (C) and values were correlated by Spearman correlation (B and D). Data is presented as the mean ±
standard error of the mean (SEM). Asterisks indicate significance: *P<.05, **P<.01, ***P<.001 by Welch’s t-test.
RESULTS 32
5.2 Extracellular heme and TNF can drive neutrophils into NETosis
We then determined how neutrophils respond to the PAMPs and DAMPs present during a
Plasmodium infection. Understanding the trigger that might lead to the activation of
neutrophils and the subsequent release of cellular contents into the circulation is crucial to
develop intervention strategies.
We isolated neutrophils from peripheral blood of healthy donors by density separation,
resulting in highly pure, inactivated neutrophils (Harbort, Soeiro-Pereira et al. 2015). These
were then stimulated ex vivo with PMA (positive control) and the following malaria-associated
immunostimulatory components:
The infected red blood cell itself, isolated from in vitro cultures of P. falciparum. It represents
the largest immunostimulatory entity during the infection, comprising all potential PAMPs
such as GPI anchors, parasite surface antigens and the misshapen erythrocyte.
The free merozoites represents the only form of the parasite that is entirely visible to the
immune system, between lysis of the old and infection of a new red blood cell. Although this
period is short it represents a potential for immune recognition.
The digestive vacuole is the organelle the parasite uses to detoxify the heme released by
digestion of hemoglobin. As merozoites burst from the dying erythrocyte this vacuole
containing the hemozoin crystal is released into the blood stream where it can be phagocytosed
by immune cells.
Free heme as we have observed before in circulation of malaria patients is the degradation
product of extracellular hemoglobin. It has a strong redox potential, can produce radicals and
is thus cytotoxic. It is also a danger signal to the immune system signifying uncontrolled
hemolysis.
After 4h, cells were fixed and analyzed for NET formation by immunofluorescence analysis
(IFA) as described before (Brinkmann, Goosmann et al. 2012). We observed no NET formation
with either infected red blood cells, free merozoites, isolated digestive vacuoles or even free
heme in unprimed neutrophils whereas PMA (positive control) induced NET formation as
published (Fig. 8 A, top panel).
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To reproduce the conditions existing during malaria in vitro we co-stimulated isolated
neutrophils with the cytokine most commonly associated with a Plasmodium infection. Tumor
necrosis  factor  (TNF)  is  present  in  the  circulation  of  malaria  patients  at  very  high
concentrations and has a priming effect on neutrophils (Chen, Zhang et al. 2014). We therefore
primed neutrophils for 15 min with 2 ng/ml TNF followed by stimulation with the
aforementioned PAMPs and DAMPs. We observed no NET induction in response to iRBCs,
free merozoites and digestive vacuoles but free heme induced NET formation comparable to
PMA in TNF primed neutrophils (Fig. 8 A, lower panel and B) yet again suggesting that
neutrophils respond to the inflammatory and hemolytic conditions present during malaria by
undergoing NETosis.
To more carefully asses the in vivo activation status of neutrophils we recruited adult malaria
patients of both sexes between the ages of 18 – 84, from whom we obtained larger volumes of
blood, enabling us to isolate peripheral neutrophils in the same fashion as described above.
These neutrophils were plated ex vivo without any further stimulation and NET formation was
assessed after a 4h incubation period. We observed that neutrophils from malaria patients
undergo NETosis to a significantly higher rate than those from healthy donors in vitro (Fig. 8
C) suggesting that the NETotic program was already initiated in the circulation of those patients
and thus carried out in vitro without the need of any further activating signals.
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Figure 8: TNF/heme stimulation induces NET formation in primary neutrophils. (A) Quantification of
NETosis in response to malaria PAMPs and DAMPs in unprimed and TNF primed (2 ng/ml) neutrophils.
Neutrophils were fixed and analyzed by immunofluorescent staining. (B) Representative images of the staining.
(C) Quantification of NETosis by neutrophils isolated from healthy individuals and malaria patients. Scale bar =
20 µm
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5.3 Heme/TNF induced NETs require NOX2-independent oxidants
and serine protease activity but do not require protein
translation nor citrullination
We and others (Chen, Zhang et al. 2014) have demonstrated the ability of heme to induce NETs
in combination with TNF but the underlying mechanism has not yet been thoroughly explored.
Heme can be sensed through TLR4 in macrophages (Dutra and Bozza 2014), suggesting an
active  sensing  of  this  DAMP  and  hence  the  engagement  of  distinct  pathways  during  heme
induced activation of cells. The characterization of signaling and effector molecules involved in
TNF/heme induced NETosis is an important step towards specific inhibition of this mechanism.
If NETs are indeed pathogenic in the setting of a Plasmodium infection these targets might
represent a strategy for intervention with disease progression.
We set out to determine by which mode of action heme induces NET formation as several
different NETosis pathways have been described (Kenny, Herzig et al. 2017). First we aimed to
determine whether heme induced NETosis depends on the generation of ROS by the NADPH
oxidase. We isolated primary neutrophils from healthy donors and patients suffering from
chronic granulomatous disease (CGD), who possess a dysfunctional NADPH oxidase and are
therefore not able to produce ROS. We observed that PMA induced NETosis is abrogated in
CGD patients but heme was still able to induce NETs (Fig. 9 A) indicting that heme induced
NETosis proceeds independently of the NADPH oxidase. We confirmed the abrogation of ROS
production in CGD neutrophils by luminescence measurements (Fig. 9 B).
To further characterize heme induced NET formation we subsequently performed inhibitor
experiments with neutrophils from healthy donors. The cells were treated with the published
NET inhibiting concentrations of each inhibitor (Kenny, Herzig et al. 2017) for 30 minutes
before stimulation.
Both PMA and heme are activators of the important signaling mediator protein kinase C (PKC)
(Graca-Souza, Arruda et al. 2002) and inhibition of PKCs function inhibits PMA induced NET
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formation. We observed that heme induced NET formation also depends on the activity of PKC
as the inhibitor treated cells were unable to produce NETs in response to heme (Fig. 9 C).
Interestingly,  we  observed  that  complete  scavenging  of  ROS  (Fig  9  D)  by  pyrocatechol  did
abrogate heme induced NET formation (Fig. 9 C) suggesting that this type of NETosis is
dependent on a different source of ROS. This could potentially be mitochondrial ROS or ROS
derived from other enzymatic sources such as xanthine oxidase.
We find that heme induced NET formation in primary human neutrophils is independent of
both protein translation (cycloheximide) and the conversion of arginine to citrulline by PAD4
(Fig. 9 B). The activity of cycloheximide was confirmed by IL-8 release assay in response to LPS
(Fig. 9 E). Amulic et al. demonstrate that NETosis relies upon enzymes associated with cell cycle
progression in actively dividing cells. Neutrophils however are terminally differentiated cells
and incapable of cell division but seem to have repurposed part of the cell cycle machinery
(Amulic, Knackstedt et al. 2017). In accordance with these prior findings about other NET
inducing stimuli, heme/TNF induced NETosis can be abrogated by inhibition of the cyclin-
dependent kinase 6 (Cdk6). Furthermore, we find that heme induced NET formation is
dependent on protease activity by the neutrophil proteases NE and Pr3 (Fig. 9 C).
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Figure 9: Heme/TNF induced NETs require NOX2-independent oxidants and serine protease activity. (A)
Quantification of NETosis in neutrophils from healthy donors and CGD patients in response to PMA and heme.
Quantification was performed as described before by IFA. (B) Oxidative burst in PMA- and heme-stimulated
neutrophils. Neutrophils were incubated with luminol and horseradish peroxidase to measure ROS production by
luminescence. Luminescence was measured kinetically in a luminometer and expressed as relative light units. (C)
Quantification of NETosis in response to PMA and heme in inhibitor treated neutrophils. (D) ROS assay of
pyrocatechol treated neutrophils. (E) IL-8 release from de novo synthesis after 18h LPS stimulation of untreated
and cycloheximide treated primary neutrophils.
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5.4 Murine Heme/TNF induced NETs require serine protease but not
protein arginine deaminase nor DNase activity
NETs are involved or implicated in three distinct pathological mechanisms:
First themacrostructure of NETs can act as a scaffold inducing platelet activation, coagulation
and eventually thrombus formation and is therefore implicated in vascular occlusion in
ischemic strokes as well as atherosclerosis (Qi, Yang et al. 2017). Vascular occlusion has long
been  hypothesized  as  one  major  factor  in  the  development  of  organ  pathology  in  malaria,
especially because iRBCs bind to both other RBCs (infected or not) and the endothelium of the
microvasculature. In a healthy individual the serum protein DNase 1 counteracts such
accumulation of large filamentous chromatin based structures by unspecific cleavage of the
DNA backbone. This enzyme is also responsible for the clearance of NETs in circulation
(Hakkim, Furnrohr et al. 2010) thus preventing these structures from facilitating coagulation.
Secondly the NET components can be directly cytotoxic (Xu, Zhang et al. 2009) and can cause
damage to endothelial cells (Gupta, Joshi et al. 2010).
Thirdly NETs and their individual components are recognized as DAMPs by both immune and
endothelial cells and lead to a proinflammatory response which might itself aggravate disease.
To  address  which  of  these  mechanisms  might  be  important  we  require  an in vivo model in
which we can compare situations where (a) NET formation is blocked and (b) the NETs that
are produced cannot be digested and keep their intact superstructure without dissemination of
individual components.
In accordance with our human data (Fig. 9), we selected NE -/- as well as NE/Pr3 -/- mice as
putative NET deficient genotypes. These two proteases are structurally very similar sequence
homologous (Campanelli, Melchior et al. 1990) and possess similar substrate specificity,
meaning that they may each be able to compensate for the loss of the other (Warnatsch,
Ioannou et al. 2015). The third neutrophil serine protease CG possesses a structurally identical
catalytic center but a slightly different substrate binding groove. CG therefore preferentially
hydrolyses peptide bonds after aromatic amino-acid residues whereas NE and Pr3 favor
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cleavage  after  valine  residues  (Pham 2006)  We assessed  both  the  NE -/-  and  the  NE/Pr3-/-
genotypes for their ability to produce NETs but did not include a CG -/- mouse as the protease
seems to play a less dominant role in NETosis.
We also decided to test a PAD4 -/- mouse despite the inhibitor not showing an effect on human
heme induced NETs. There is ongoing controversy in the field as to whether NET formation
requires PAD4 activity or not as described in the Introduction (Konig and Andrade 2016). We
therefore aspired to back our human inhibitor data with the appropriate observations in the
mouse.
Lastly we decided to assess the capability of DNase 1 deficient mice to make NETs, as they would
later  in  the  infection  model  allow  us  to  distinguish  between  effects  mediated  by  the  NET
macrostructure and effects dependent on the solubilization of protein components initially
associated with NETs. No role is described for DNase 1 in the formation of NETs, but
neutrophils from DNase deficient mice were never tested with regards to their capacity to make
NETs in vitro. We therefore decided to include DNase deficient neutrophils in our analysis.
As shown in Figure 10, only neutrophils isolated from the peritoneum of mice deficient in both
NE and Pr3 were entirely unable to produce NETs in response to heme/TNF costimulation.
While PAD4 deficiency showed no effect, mice deficient for NE showed an intermediate
phenotype with a reduction of NET formation of about 50% in response to heme/TNF (Fig. 10
B).  As  expected  the  DNase  1  deficient  neutrophils  produced  NETs  normally.  Interestingly
microscopic analysis revealed that neutrophils from NE/Pr3 -/- mice still become permeable in
response to heme but fail to fully decondense their chromatin (Fig. 10 A).
This finding allowed us to proceed with our in vivo analysis of NETs in Plasmodium infection
as we have fulfilled the requirements outlined above. The NE/Pr3 deficient mice are incapable
of producing NETs in response to TNF/heme costimulation and will therefore allow us to assess
the role  of  NETs in general.  The DNase 1 deficient  mice on the other hand are still  able  to
produce NETs but fail to solubilize NET components by extracellular digestion of the DNA
backbone. Infection of these two mouse strains will allow us to determine whether NETs are
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involved in the pathogenesis of malaria and whether this is due to their macrostructure or to
the systemic dissemination of individual components.
Figure 10: murine heme/TNF induced NETs require serine proteases but not protein arginine deaminase nor
DNase 1 activity. (A) Representative images of immunofluorescence staining of murine neutrophils isolated from
peritoneal lavage fluid after repeated casein injection. Cells were stimulated with PMA or heme after TNF priming
in vitro and subsequently fixed in 2% PFA. (B) Quantification of NET formation of different genotypes in response
to PMA and heme. The quantification was carried out using the method described by Brinkman et al. (C)
Neutrophil cell counts in the peritoneal lavage fluid after repeated injection of casein. Neutrophils must
extraversate out of the blood into the peritoneum to be detected here. Scale bar = 10 µm
To verify that our knockouts specifically affect NETs, we also quantified neutrophil
extravasation rates into the peritoneal cavity. Neutrophils infiltrate into the afflicted organs of
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mice and humans suffering from severe cases of malaria (Rocha, Marques et al. 2015, Bostrom,
Schmiegelow et al. 2017). Neutrophil extravasation has been proposed to be at least partly
dependent on the activity of proteases such as NE and Pr3. We therefore assessed the neutrophil
efflux in response to an inflammatory stimulus. We injected a 9 % casein solution into the
peritoneum of mice of all genotypes. We then lavaged the peritoneum with sterile PBS and
determined the number of cells that had migrated there (Fig. 10 C). No significant differences
were seen although the DNase deficient mice seemed to show a trend towards more neutrophil
mobilization.
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6 NET components are pathogenic in malaria
WE show that, just like human neutrophils, murine neutrophils commit to NETosis in response
to heme/TNF stimulation and that this process depends on the activity of the granular proteases
NE and Pr3 while DNase 1 deficiency does not abrogate this process. These observations
equipped us with the right tools to address the potential mechanism of NET induced pathology.
We decided to use the P. chabaudi mouse model of malaria due to two important reasons:
a) The infection resembles the one that occur in humans as it is synchronized and cyclic.
Same as in the human host parasites burst from the infected red blood cell all at once.
Furthermore, P. chabaudi cytoadheres to the endothelium in a well-defined pattern,
unlike other rodent malaria models. The infection is chronic, hemolytic and eventually
leads to organ damage – in this case in the liver. Unlike the infection with P. berghei,
there is no mortality described for P. chabaudi.
b) A role for neutrophils in the pathology of this infection has already been established
(Rocha, Marques et al. 2015). In brief, mice were depleted of neutrophils by repeated
antibody injection over the course of the P. chabaudi infection. This treatment
abrogated organ damage.
Organ damage is induced during a P. chabaudi infection in the tissues that the parasitized red
blood cells sequester to, namely the liver and the lung. The read out for cytoadhesion-mediated
organ pathology in this model are the hepatocyte specific enzymes aspartate aminotransferase
(AST) and alanine aminotransferase (ALT), which are released into circulation only upon
necrotic cell death in the liver. Pathology in the lung can be assessed by pathological scoring of
lung sections, which can identify necrotic events and immune cell infiltration.
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6.1 NET components in the blood of P. chabaudi infected mice
We infected mice of the three described genotypes (WT, NE/Pr3 -/- and DNase -/-) with 1x104
iRBCs injected i.v. directly into the bloodstream, and mice were sacrificed on days 7, 9, 11 and
13 post infection. On these days, blood samples were collected and the livers were fixed in
paraformaldehyde for microscopic analysis. The blood was separated into plasma and the
cellular fraction. Plasma samples were further analyzed by ELISA whereas the cell fraction was
analyzed by fluorescence activated cell sorting (FACS).
Other groups have described that neutrophils do not participate in the clearance of parasites
and that the depletion of neutrophils does not affect the growth of the parasite (Rocha, Marques
et al. 2015, Sercundes, Ortolan et al. 2016). In accordance with this we found that neither the
absence of the proteases NE and Pr3 nor of the endonuclease DNase 1 had any significant effect
on the growth of the parasite (Fig. 11 A) as determined by counting of the percentage of infected
iRBCs in thin blood smears of the mice (parasitemia).
Interestingly we could observe an accumulation of NETs in circulation of WT mice which was
not observed in the NE/Pr3 deficient mice, consistent with our in vitro findings. Surprisingly,
DNase I deficient mice also showed absence of circulating NETs (Fig. 11 C). NETs were
measured as NE/DNA complexes in the plasma of mice by sandwich enzyme linked
immunosorbent assay (ELISA). We initially expected the DNase -/- mice to exhibit increased
NET concentrations in circulation due to an impaired clearance, however NETs bind to
endothelial cells (McDonald, Urrutia et al. 2012) and are sequestered away from circulation if
they are not broken into smaller fragments. DNase 1 is therefore required for solubilizing NET
components and releasing them systemically.
We went on to determine the concentrations of individual NET-associated molecules and
observed an accumulation of both extracellular nucleosomes and NE in the circulation of
infected WT mice. Strikingly, neither component was present in either of the knockout
genotypes (Fig. 11 D and E).
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To gain a better understanding of how neutrophils contribute to pathology, we determined
neutrophil numbers in the blood stream by FACS using an anti-Ly6G/C antibody in
combination with an anti-CD115 antibody as describe elsewhere (Dunay, Fuchs et al. 2010).
This combination of antibodies allows a clear distinction of neutrophils from other circulating
immune cells such as inflammatory monocytes. Neutrophils can be observed as Ly6G/C high
and CD115 negative. This analysis revealed an increase in the neutrophil population from day
7 of the infection in WT mice. Neutrophil numbers continuously rise over the course of the
infection, but drop back to basal levels as parasite burden decreases. Neither of the deficient
genotypes displayed an accumulation of neutrophils comparable to the WT at any time during
the infection (Fig. 11 B).
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Figure 11:  Increased NET components and neutrophil  to leukocyte ratio in P. chabaudi infected mice. (A)
Parasitemia  of  infected  mice  as  determined  by  counting  of  thin  blood  smears.  Images  were  taken  at  a  63X
magnification and at least 500 red blood cells were counted per samples. (B) Ratio of neutrophils to leukocytes
over the course of the infection determined by FACS analysis of whole blood samples. Neutrophils were defined
as  CD45  +,  CD3  -,  Ly6G/C  high,  CD115  -.  The  population  was  confirmed  by  SSC/FSC  location.  (C)  NET
quantification in plasma of mice by sandwich ELISA detecting NE/DNA complexes. Quantification of extracellular
nucleosomes (D) and neutrophil elastase (E) by sandwich ELISA.
The group size of all data presented is n = 6. Data is presented as the mean ± standard error of the mean (SEM).
Asterisks indicate significance: *P<.05, **P<.01, ***P<.001 and ****P<0.0001 by two-way analysis of variance
(ANOVA) comparison of 3 groups. Color of the asterisks indicate which genotype they refer to.
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6.2 NET components liberated by serum DNase 1 drive pathology
We observed prominent macroscopic changes in the livers of the animals over the course of the
infection. We noted that necrotic patches start to manifest on the organs as early as day 9 and
the organs display severe darkened discoloration at the later time points of the infection (Fig.
12 A). Interestingly neither white necrotic patches nor the change in color was apparent in the
livers of deficient mice.
WT mice showed a drastic increase in extracellular AST in the plasma starting from day 9 of
the infection, which peaked on day 11 together with the parasitemia (Fig. 12 B). This indicates
liver damage and hepatocyte death. Remarkably both knockout genotypes exhibit a complete
abrogation  of  liver  damage,  as  measured  by  circulating  AST  and  when  livers  are  assessed
macroscopically (Fig. 12 A and B). To verify this phenotype, we assessed liver damage of all
three genotypes by pathological scoring of hematoxylin and eosin (H&E) stained liver sections
of the infected mice (Fig. 12 C and D). This analysis was carried out in a blinded fashion by the
iPATH Charité University Hospital pathology division and revealed large necrotic patches in
the livers of infected WT mice which were almost completely absent in both deficient genotypes
(Fig. 12 C). We were also able to observe an infiltration of immune cells into the liver as well as
the accumulation of malaria pigment over the course of the infection (arrows figure 12 D) both
of which were absent in the knockout mice.
The absence of pathology and discoloration in the livers of NE/Pr3 -/- mice indicates that NETs
are  a  crucial  factor  in  the  development  of  organ  pathology  during  a  malaria  infection.
Furthermore, the absence of pathology in DNase 1 -/- mice indicates that this systemic effect is
due to extracellular digestion of the DNA backbone of NETs and thus release of individual NET
components.
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Figure 12: NET components liberated by serum DNase 1 are pathogenic in a P. chabaudi mouse model
of malaria. (A) Representative images of dissected livers of uninfected mice and 11 days post infection of all
genotypes. (B) Concentration of aspartate aminotransferase in plasma of mice over the course of the experiment.
Measurements were conducted by a routine veterinary laboratory (SYNLAB vet). (C) Pathological score of livers
over the course of the infection, determined blind by the pathology unit of the Charité University Hospital. (D)
Representative images of H&E stained liver sections used for pathological scoring.
The group size of all data presented is n = 6. Data is presented as the mean ± standard error of the mean (SEM).
Asterisks indicate significance: *P<.05, **P<.01, ***P<.001 and ****P<0.0001 by two-way analysis of variance
(ANOVA) comparison of 3 groups. Color of the asterisks indicate which genotype they refer to.
Scale Bar = 100 µm
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6.3 NET components drive pathology by controlling parasite
sequestration and neutrophil infiltration of livers
The absence of discoloration and pigment in the NET release or degradation deficient
genotypes led us to determine the sequestration frequency of infected red blood cells in the liver.
The black discoloration of organs occurs during human disease as well (Haldar, Murphy et al.
2007) and indicates accumulation of hemozoin in the afflicted organs.
As described before, the parasite binds to the endothelium of liver micro capillaries in infected
WT mice (Fig.13 A). Such accumulation was absent in both NE/Pr3 and DNase 1
-/- mice (Fig. 13 A). Representative H&E stained images are shown in Fig.13 C. The first picture
shows a large blood vessel in the liver and green arrows point to infected RBCs in circulation.
These represent parasitemia and are not counted as sequestered parasites. The two lower images
show parasites in the microvasculature of the tissue (black arrow) which are counted as
sequestered parasites (Fig.13 C).
Parasite sequestration both leads to and is enhanced by endothelial activation. Parasitized red
blood cells bind to adhesion factors such as VCAM, ICAM, CD36 and EPCR (Cunningham,
Lin et al. 2017, Kessler, Dankwa et al. 2017) that are all upregulated upon activation of
endothelial cells. Sequestration of some iRBCs therefore increases the sequestration of other
iRBCs in a forward cycle. The same adhesion molecules also mediate the recruitment of
immune cells into the microvasculature of afflicted organs, which then in turn enhance the
inflammatory environment by producing and releasing their own repertoire of immune
mediators.
We wanted to determine whether the sequestration, or lack thereof, in the deficient genotypes
was mirrored in the number of neutrophil infiltrates present in the liver. The quantification in
the livers was performed by immunofluorescent staining of paraffin sections using a
neutrophil-specific anti-calgranulin A antibody generated at the Max-Planck Institute for
Infection Biology in Berlin. Entire liver sections were then scanned using a ZEISS Axio Scan Z1
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and the signal intensity was quantified. Representative images are shown in figure 13 D
(Calgranulin A shown in red).
Quantification showed an influx of neutrophils into the liver of infected WT mice starting on
day 9 of the infection, which decreased as the infection was cleared towards day 13. Neither the
NE/Pr3 nor the DNase deficient mice showed comparable infiltration of cells into the liver (Fig.
13 B).
The lack of sequestration and immune cell infiltration in the deficient genotypes potentially
explains the lack of liver damage in these animals, as well as the absence of macroscopic changes.
The black discoloration visible in the livers of infected WT mice is most likely due to the
pigment hemozoin present in both parasites and professional phagocytes binding to the
microvasculature of the organ and since this does not happen in the knockout genotypes no
discoloration  occurs.  We  conclude  that  liberated  NET  components  are  involved  in  the
activation of endothelial cells and thereby upregulate surface adhesion receptors leading to both
sequestration of infected red blood cells as well as accumulation by immune cells.
RESULTS 50
Figure 13: NET components drive pathology by controlling parasite sequestration and neutrophil
infiltration of livers.  (A) Quantification of parasite sequestration in the liver performed by microscopic analysis
of H&E stained liver sections. (B) Quantification of neutrophil infiltrates into the livers of all three genotypes over
the  entire  liver  section  performed  using  an  Axioscan  Z1  (C)  Representative  images  of  H&E  stains  at  400X
magnification, black arrows indicate sequestered parasites. (D) Representative images of immunofluorescent
stains of liver sections from all three genotypes at peak liver pathology, using the neutrophil marker Calgranulin
A. Scale bars: (C) = 20 µm and (D) = 100 µm
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6.4 NET components induce an inflammatory environment favoring
neutrophil recruitment and extravasation
So far we were able to show that NET components are involved in inducing neutrophil
expansion in the blood, infiltration of neutrophils into the liver and in liver pathology. We
hypothesized that liberated NET components regulate de novo production of neutrophils, also
known as emergency granulopoiesis.
Neutrophils are produced in the bone marrow from hematopoietic precursors and this process
is regulated by cytokines, most notably G-CSF and the IL-1 family. (Summers, Rankin et al.
2010). We thus set out to define the inflammatory environment in the different genotypes. To
do so we performed a multiplex cytokine analysis using a Bio-Plex Multiplex Immunoassay
system. This bead based assay allows detection of multiple immune mediators in the same
plasma sample. Analysis of the data revealed a proinflammatory environment with increased
levels of IL-1α, IL-6, IL-17, G-CSF, IFN-γ and TNF in the infected WT mice (Fig. 14 A). Once
again, the deficient mice showed decreased levels of all the above-mentioned cytokines in
circulation although differences were not always clearcut. Strikingly, G-CSF and IL-1, which
regulate emergency granulopoiesis, were greatly reduced in knockout mice (Fig. 14 A),
explaining the observed neutrophilia in infected WT mice that is absent in the deficient
genotypes. Reduced circulating levels of G-CSF were confirmed by regular ELISA in the same
samples (Fig. 14 B). Furthermore, IL-17, another proinflammatory cytokine that activates
granulopoiesis via G-CSF induction, was also significantly reduced in knockout mice.
Interestingly IL-17 and TNF can act synergistically on endothelial cells to induce release of G-
CSF but also to promote ICAM display and neutrophil extravasation (Bosteen, Tritsaris et al.
2014)
We conclude that the absence of NETs (NE/Pr3 -/-) or NET processing (DNase 1 -/-) prevents
expression of inflammatory cytokines driving emergency granulopoiesis. The
immunomodulatory effect of NET components was not limited to granulopoiesis, as other
cytokines with pleiotropic effects on the inflammatory cycle, such as TNF, IFNγ and IL-10, were
also affected.
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We next wanted to test if this effect is specific for neutrophils or if other immune cells are also
affected.
Figure 14: NET components have a proinflammatory effect in a P. chabaudi mouse model of malaria. Bioplex
analysis of the plasma generated by infection of WT, NE/Pr3 -/- and DNase 1 -/- mice with the rodent parasite P.
chabaudi. The group size of all data presented is n = 6. Data is presented as the mean ± standard error of the mean
(SEM).
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6.5 Reintroduction of NET components restores pathology in NET-
deficient mice
To confirm that the observed lack of pathology is due to absence of circulating NETs, rather
than some other function of neutrophils or DNase 1. We also wanted to gain more insight into
the mechanism by which NETs cause emergency granulopoiesis and endothelial activation.
We therefore decided to infect NET-deficient NE/Pr3 -/- mice in the same fashion as before
and then complement them with exogenously-provided NETs via injection, to prove that NETs
themselves are pathogenic in a malaria setting.
The NETs to be injected were generated in vitro from WT peritoneal neutrophils. These cells
were stimulated for 18 hours with PMA. The PMA was washed away and the remaining NETs
were scraped of the tissue culture dish. In their untreated form, NETs form viscous clumps that
are impossible to accurately pipet or inject. Samples were therefore sonicated before the DNA
concentration was determined by picogreen assay. We injected each mouse with an amount of
NET DNA that corresponds to the total amount measured in previous experiments (400
ng/mouse).
To identify which specific component of the NET structure is responsible for the observed effect
we also decided to inject the following:
DNase treated NETs: We treated the NETs to completion with DNase 1 which was afterwards
removed  by  immunoprecipitation.  If  the  DNA  part  of  the  NETs  is  responsible  for  the
immunostimulatory effects, the reinjection of these samples should exhibit no effect.
Nucleosomes: Nucleosomes are complexes of DNA and histones and represent the major
structural component of chromatin and NETs. We purified mouse nucleosomes from
chromatin from bone marrow derived macrophages (BMM) by subcellular fractionation. If the
neutrophil specific proteins on the NETs are responsible for the effects that were observed
before, the injection of these samples should exhibit no effect on the pathology.
Sivelestat treated NETs: The neutrophil proteases NE and Pr3 are not only important for the
formation of NETs but also remain associated and continue to be active while bound to NETs.
Furthermore they have also been identified as mediators of NET immune stimulatory functions.
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Sivelestat irreversibly inhibits the activity of these two proteins. We treated in vitro produced
NETs with the inhibitor and subsequently washed it away, before injection into mice. If the
proteases are responsible for the observed effects, injection of these samples should be unable
to restore pathology.
As displayed in Figure 15 A the injection of different types of NET preparations did not affect
parasite growth in the animals. Interestingly injection of sonicated or DNase treated NETs fully
restored pathology in NE/Pr3 -/- mice, as demonstrated by detection of circulating liver
enzymes (AST) comparable to the levels in WT mice, while once again the infected NE/Pr3 -/-
treated with only buffer showed very little to no pathology (Fig. 15 B). On the other hand,
injection of protease inhibitor-treated NETs or purified nucleosomes failed to restore pathology
in NE/Pr3 knockouts. These findings confirm that NET components are the detrimental factor
driving the liver pathology and identify neutrophil serine proteases as the key
immunomodulatory molecules.
We then measureed G-CSF in the circulation of these animals and observed a result comparable
to the behavior of the liver enzymes (Fig. 15 C). No circulating G-CSF is found in uninfected
mice of either genotype when they are injected with sonicated NETs, indicating that NET-
associated proteases are necessary but not sufficient for induction of this cytokine. This
situation is perhaps functionally analogous to the ‘two-hit’-mechanism required for TNF/heme
activation of NETosis. As shown in Fig.14 a broad range of cytokines is present in the blood
stream of infected mice before G-CSF can be detected. Interestingly IFNφ can  enhance  the
production of G-CSF by adherent monocytes upon LPS stimulation in humans (Ref 1993). G-
CSF production is also regulated by TNF, IL-1 and IL-17, which are present early on during
P. chabaudi infection (Fig 13).
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Figure 15: NET components are sufficient to restore pathology in NET-deficient P. chabaudi infected mice.
(A)  Parasitemia  of  infected  mice  as  determined by  counting  of  thin  blood smears.  Images  were  taken at  a  63X
magnification and at least 500 red blood cells were counted per samples. (B) Concentration of aspartate
aminotransferase in plasma of mice over the course of the experiment. (C) Concentration of G-CSF was
determined  by  sandwich  ELISA  of  plasma  samples.  The  group  size  of  all  data  presented  is  n  =  5  -10.  Data  is
presented  as  the  mean  ±  standard  error  of  the  mean  (SEM).  Asterisks  indicate  significance:  *P<.05,  **P<.01,
***P<.001 and ****P<0.0001 by Mann-Whitney test.
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6.6 NET components induce adhesion molecules in Plasmodium
chabaudi malaria
Our  work  shows  a  lack  of  pathology  in  mice  deficient  in  either  the  production  or  the
extracellular  digestion  of  NETs.  This  phenomenon  coincides  with  a  lack  of  G-CSF  release,
reduced neutrophil infiltration into affected organs and reduced sequestration of infected red
blood cells in the microvasculature of the liver.
The pathology of P. falciparum – the parasite responsible for most malaria related deaths still
occurring in the world – relies partly on the binding of iRBCs to the endothelium of afflicted
organs by ICAMs, VCAMs, CD36 and most recently described endothelial protein C receptor
(EPCR) (Tuikue Ndam, Moussiliou et al. 2017)
The P. chabaudi mouse model reflects human disease closely as pathology is dependent on the
expression of ICAM-1. It is required for cytoadhesion and hence sequestration of iRBCs in the
microvasculature. ICAM-1 deficient mice show less pathology during a P. chabaudi infection
(Cunningham, Lin et al. 2017).
Because we observed decreased sequestration in both deficient strains we set out to determine
the expression of ICAM-1 in the livers of the infected cells. Liver sections were stained by
antibody staining, scanned using a ZEISS Axio Scan system (representative images in Fig. 16 B)
and percent ICAM-1 signal was quantified blinded by a trained technician. We observed an
increase in ICAM-1 expression in the livers of infected WT mice over the course of the infection
(Fig. 16 A) that coincides with the peak in parasite burden, sequestration and liver damage.
Interestingly, both the NE/Pr3 and the DNase deficient mice did not show an increase in ICAM-
1 expression in the liver during infection.
ICAM-1 can be shed from the surface of cells by an uncharacterized mechanism and to
unknown consequence. The presence of soluble ICAM-1 in circulation can however serves as
an indicator for vascular activation and an overall inflammatory setting (Witkowska and
Borawska 2004). We measured sICAM-1 in the plasma of infected WT mice by sandwich ELISA
and observed a significant increase when compared to uninfected mice. Interestingly the
injection of NETs by themselves did not induce sICAM-1 in uninfected WT mice (Fig. 16 C).
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NE/Pr3 deficient mice failed to induce sICAM-1 in response to P. chabaudi infection. Strikingly,
and in accordance with our observations regarding liver damage and G-CSF production,
injection of NETs into infected NE/Pr3 mice restored sICAM-1 levels. In contrast to our
previous findings however, this is also true for Sivelestat treated NETs (Fig. 16 C) and might
indicate that a less specific neutrophil protease inhibitor might be an even more promising
treatment candidate. In DNase deficient mice we observed no ICAM-1 induction on the liver
vasculature throughout the infection but do observe an increase in sICAM-1 comparable to WT
mice (Fig. 16 C).
EPCR is a transmembrane receptor classically known for its capacity to bind protein C and
activated protein C and thus being an important factor in anticoagulation. Membrane-bound
EPCR also exhibits cytoprotective effects by inhibiting apoptosis (Mohan Rao, Esmon et al.
2014). Interestingly, infection, production of cytokines and ROS can lead to the cleavage of
membrane-bound EPCR by metalloproteases and the release of a soluble form of the receptor
(Xu, Qu et al. 2000). In stark contrast to its former role, sEPCR binds APC and inhibits its
function thus propagating a coagulation and thrombus formation (Mohan Rao, Esmon et al.
2014).
The role of EPCR in the pathogenesis of severe malaria is just now beginning to emerge and
there is no coherent understanding of the underlying mechanisms. Parasite binding to
membrane-bound EPCR through specific subtypes of PfEMP1 is clearly associated with disease
severity  (Turner,  Lavstsen  et  al.  2013)  but  EPCR  also  seems  to  be  lost  at  sites  of  parasite
sequestration (Moxon, Wassmer et al. 2013). Soluble EPCR is positively correlated with disease
severity in children suffering from cerebral malaria (Moussiliou, Alao et al. 2015).
To further our understanding of NET mediated malaria pathology, we measured sEPCR
concentrations in the plasma of all three genotypes. WT mice showed a drastic increase in
plasma sEPCR levels at the peak of pathology that was completely absent in both NE/Pr3 and
DNase -/- mice.  Astonishingly, reinjection of fragmented NETs completely restored plasma
sEPCR levels in NE/Pr3 deficient mice (Fig. 16 D).
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Taken together these data suggests that NET components, and specifically NET-bound serine
proteases, are crucial in generating a proinflammatory environment during a malaria infection,
leading to cytokine production, immune cell recruitment and endothelial activation. These
changes promote parasite sequestration and immune cell infiltration and eventually lead to
organ damage.
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Figure  16:  NET  components  induce  endothelial  activation  in P. chabaudi malaria. ICAM-1 induction was
determined in livers of infected animals by immunofluorescent staining and subsequent microscopy. The scanning
system used is a ZEISS Axio scan and quantification was carried out blindly by a trained technician (A & B). ICAM-
1 concentrations in plasma of infected animals was determined by sandwich ELISA (C). EPCR concentration in
plasma was determined by sandwich ELISA (D). The group size of all data presented is n = 5 - 10. Data is presented
as the mean ± standard error of the mean (SEM), each dot represents one biological replicate. Asterisks indicate
significance: *P<.05, **P<.01, ***P<.001 and ****P<0.0001 by two-way analysis of variance (ANOVA) comparison
of 3 groups (A) or Mann-Whitney test (C & D). Scale bar = 100 µm
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7 G-CSF blocking antibodies decrease malaria pathology
We continued our work by trying to translate the findings described above into a veritable
therapeutic approach against organ damage in malaria. We have seen an increase in circulating
G-CSF that coincides with increased levels of circulating neutrophils as well as ultimately organ
damage. Additionally, G-CSF is found in human patients suffering from complicated malaria
and is quickly reduced upon treatment with anti-malarials (Ref 2000 Stoiser).
We set out to treat mice with anti-G-CSF blocking antibodies similar to previous studies (Ref
Morris 2015). We used a single dose of 100 µg of antibody. Anti-G-CSF treatment did not affect
the parasitemia (Fig 17 A) but significantly decreased the amount of circulating liver enzymes
(AST), compared to animals injected with an isotype control (Fig. 17 B). These data suggest that
therapies targeting G-CSF induction may represent a treatment strategy in malaria
Figure 17: G-CSF blocking is protective in P. chabaudi malaria. (A) Parasitemia of infected mice as determined
by counting of thin blood smears. Images were taken at a 63X magnification and at least 500 red blood cells were
counted per samples. (B) Concentration of aspartate aminotransferase in plasma of mice over the course of the
experiment. The group size of all data presented is n = 6 - 10. Data is presented as the mean ± standard error of
the  mean  (SEM),  each  dot  represents  one  biological  replicate.  Asterisks  indicate  significance:  *P<.05,  **P<.01,
***P<.001 and ****P<0.0001 by student’s t-test
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Considering the positive effect, we observed by treating mice with anti-G-CSF blocking
antibodies we evaluated whether this might be a possible approach in human patients. We
therefore quantified the amount of G-CSF present in the plasma of the patients that we recruited
to our initial study. We observed a significant increase of G-CSF in Plasmodium infected
individuals as compared to healthy donors (Fig.18)
Figure 18: G-CSF is induced in patients suffering from malaria. Concentration of G-CSF was determined by
sandwich ELISA of plasma samples. Data is presented as the mean ± standard error of the mean (SEM), each dot
represents one biological replicate. Asterisks indicate significance: *P<.05, **P<.01, ***P<.001 and ****P<0.0001
by Welch’s t-test
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DISCUSSION
Malaria is an extremely diverse disease with symptoms that range from mild fatigue, fever and
rigor to single or multiple organ failure, respiratory distress, jaundice and eventually lethal
neurological  complications  in  cerebral  malaria  (CM)  (Coban,  Lee  et  al.  2018).  In  spite  of
extensive research on malaria pathology in hope of novel therapeutic approaches, the
underlying mechanisms remain elusive.
Historically the pathogenesis of malaria was attributed to vascular occlusion mediated by
parasite adherence to the endothelial walls of the microvasculature and to other infected and
non-infected red blood cells, leading to the formation of thrombus-like complexes that block
and rupture vessels. These events are comparable to micro strokes. The immune system plays
an important role in the pathological processes underlying organ damage in a Plasmodium
infection. In the late 1980s and early 1990s, TNF- and IFN-γ blocking antibodies were shown
to prevent CM in the P. berghei mouse model (Grau, Heremans et al. 1989, Grau, Piguet et al.
1989). Subsequently a role for almost every immune cell including γδ-Tcells, NKT-cells, CD8-
T cells, monocytes, macrophages and neutrophils and a wide range of cytokines and
chemokines  -  CXCL10,  IL-17,  IL-12p40,  IL-10,  IFNγ,  TNF  and  GCSF  -  were  described  in
malaria pathogenesis (Artavanis-Tsakonas, Tongren et al. 2003), highlighting the complexity
of disease mechanisms.
Prior to this project, there was fragmented information about the role neutrophils play in a
malaria infection. By Ly6 G/C mediated depletion, neutrophils were attributed a role in the
pathophysiology of experimental cerebral malaria (Chen, Zhang et al. 2000) although this effect
is hard to interpret because the antibody also depletes monocytes, macrophages and to some
degree  CD8+  T-cells.  In  a  more  specific  approach  Rocha  et  al.  showed  that  depletion  of
neutrophils by anti-Ly-6G antibody injection abrogates liver damage and reduces neutrophil
infiltration into the liver in P. chabaudi infected mice (Rocha, Marques et al. 2015). They also
report an inflammatory and type 1 interferon responsive phenotype for human neutrophils
isolated from P. vivax infected individuals. This observation coincides with several other
findings, namely by Mohammed et al. and Feintuch et al., who observed a direct correlation
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between circulating neutrophil granular proteins such as NE, Pr3, MPO, lysozyme and lipocalin
in circulation of patients and severity of disease (Mohammed, Elghazali et al. 2003, Rocha,
Marques et al. 2015, Feintuch, Saidi et al. 2016).
NETs have been described in patients infected with P. falciparum albeit the authors show blood
smears from peripheral blood of these patients stained with either Giemsa or DAPI containing
cloud-like DNA structures but did not assess colocalization with neutrophil proteins (Baker,
Imade et al. 2008). A second paper addressing the possibility of NET formation published by
Sercundes et al. shows cloud like structures of MPO in tissue sections of lungs of P. berghei
ANKA infected DBA/2 mice but does not address the systemic release of NETs (Sercundes,
Ortolan et al. 2016). Here, we provide definitive evidence that bona fide NETs are released
during P. falciparum infections and show that they are induced via a heme-/TNF and ROS
dependent mechanisms.
Furthermore, we demonstrate, in a P. chabaudi mouse model, that NETs are proinflammatory
during a malaria infection. NETosis releases molecules that induce proinflammatory cytokines,
emergency granulopoiesis, endothelial activation, immune cell recruitment and tissue
infiltration as well as parasite sequestration. These results suggest that NET formation might be
a potential treatment target in malaria.
8 NET formation in response to Plasmodium DAMPs and PAMPs
The first part of this thesis addresses whether NETs are released in the circulation of patients
suffering from malaria. We further investigate by which mechanism Plasmodium infection
might lead to such an induction of NETosis. Here we interpret our findings and discuss their
relevance to the field as well as implications for future research conducted in the field of malaria
pathology.
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8.1 Correlation between hemolysis and circulating NETs
We conducted a field study in a malaria endemic region in Gabon and measured NETs in the
circulation of malaria patients. We showed a positive correlation between hemolysis (by
extracellular heme quantification) and NET concentration (Fig. 7).
The presence of NETs was previously suggested in malaria patients (Baker, Imade et al. 2008),
but this study only showed cloud-like DNA-containing structures on Giemsa stained blood
smears of infected individuals. To properly identify a NET and characterize its neutrophilic
origin it is necessary to observe colocalization of DNA with neutrophil proteins such as NE, Pr3
or MPO. The sandwich ELISA approach that we used to identify the presence of NETs in
circulation of infected individuals is based on this colocalization of NE and DNA. Additionally,
using in vitro generated NETs to produce a standard curve allows us to quantitatively asses the
amount of NETs present in individual patients. Future studies might use this tool to study the
correlation between NETs and disease severity or onset, thus possibly supplying an interesting
diagnostic tool to predict whether severe disease might develop.
Because malaria is a hemolytic disease, the presence of extracellular heme in circulation of
malaria patients is not all together surprising, but has important implications for the disease
progression. Heme consists of a tetrapyrrole ring with a central iron atom (Fe) coordinated to
the pyrrole rings, which readily and reversibly changes its oxidation state. It is a ubiquitous
prosthetic group used to catalyze oxidative reactions, electron transfer processes and the
delivery of oxygen to cells (Dutra and Bozza 2014). While these abilities are essential to many
biological processes, they can also be pathological. Free heme oxidizes lipids and proteins
(Vincent 1989) and damage DNA (Aft and Mueller 1984). Furthermore, the hydrophobic
porphyrin ring intercalates in lipid layers destabilizing biological membranes by increasing
their permeability leading to lysis of the affected cells (Schmitt, Frezzatti et al. 1993). On top of
that, heme also leads to the production of free radicals through the Fenton reaction, which
catalyzes hydroxyl radicals from the reaction of Fe with H2O2.
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Fig.19: Chemical equation of the Fenton reaction.
Despite these hydrophobic properties, cells sense heme by specific receptors. In macrophages
recognition of free heme by TLR4 leads to activation of MyD88 but not TRIF dependent
intracellular signaling cascades. MyD88, in turn, activates the mitogen-dependent proteins
kinases (MAPK) and further downstream NF-ϕB thus inducing inflammatory cytokines like
TNF, IL-6 and KC (Takeuchi  and Akira 2010).  Heme also induces leukotriene B4 (LTB4),  a
chemoattractant for neutrophils, by macrophages in vivo (Monteiro,  Pinheiro  et  al.  2011).
Interestingly, heme induces neutrophil migration in vitro in the absence of macrophages which
is inhibited by Pertussis toxin indicating the involvement of a G-protein coupled receptor
(GPCR) in heme sensing by neutrophils (Porto, Alves et al. 2007). Although heme induced NET
formation itself is clearly established, the specific receptor required for this activation is not
known. Both TLR4 as well as a range of GPCRs are potential candidates.
Heme is present in large quantities within the hemoglobin contained in red blood cells making
it a critical factor to be released in all hemolytic diseases (sickle cell disease, hemorrhagic fevers,
malaria, α-thalassemia, etc.). The danger of free heme is reflected in a plethora of control
mechanisms aimed at dealing with it. Hemoglobin is bound by Haptoglobin in circulation
preventing free heme from being released from the protein (Melamed-Frank, Lache et al. 2001).
Additionally, the heme scavenger hemopexin binds free heme, inhibits its oxidative property
and transports it to intracellular compartments through the macrophage receptor CD91
(Hvidberg, Maniecki et al. 2005). Intracellularly heme is catabolized by heme oxygenase 1 (HO-
1) into billiverdin, CO and Fe, which is then recycled by ferritin. In a final fail-safe mechanism,
heme binds and is cleared by serum albumin. Nevertheless, in severe hemolysis these
endogenous scavenging mechanisms are overwhelmed and heme accumulates in biological
fluids.
Interestingly, the survival of mice infected with P. berghei depends on their ability to express
HO-1 indicating deleterious effects of heme in Plasmodium infections (Ferreira, Balla et al.
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2008). Similarly, heme induces NETs and drives the pathology in patients and mice suffering
from sickle cell disease (Chen, Zhang et al. 2014). The positive correlation we observed between
the  amount  of  NETs  and  free  heme  in  circulation  supports  the  notion  that  a  heme  related
mechanism of disease progression exists in malaria patients. Larger studies should address the
importance of heme in malaria patients since it might represent a promising therapeutic target.
Decrease  of  heme  concentration  and  activity  might  have  at  least  four  beneficial  effects  on
afflicted patients: (1) Heme lyse RBCs (Chiu and Lubin 1989) and could lead to bystander
hemolysis and severe anemia in malaria patients. This seems to be a self-propagating
mechanism since lysis of RBCs will release hemoglobin and eventually heme into circulation.
(2) Heme activates endothelial cells to express adhesion molecules, like ICAM-1 and VCAM-1
(Belcher, Chen et al. 2014), which mediate both parasite sequestration and neutrophil adhesion.
(3) Heme activates macrophages to produce inflammatory stimuli, especially TNF by engaging
TLR4 (Figueiredo, Fernandez et al. 2007) thus propagating inflammation and activation of
other immune cells such as neutrophils (see next section). Once again, this is a positive feedback
loop since TNF, in turn, primes macrophages for necroptosis, an inflammatory programmed
form  of  necrotic  cell  death.  (4)  Lastly,  heme  activates  PKC  in  neutrophils  leading  to  ROS
generation, inducing the expression of adhesion molecules, the production of IL-8 and the
release of NETs (Chen, Zhang et al. 2014). The induction of NETosis by heme has previously
been described, although the underlying mechanism, the required signaling pathways and
effector molecules remain to be determined.
8.2 Mechanism of malaria associated NET formation
Strategies targeting extracellular heme are a possible approach to block malaria pathogenesis
but would only combat one potential stimulus. Malaria is a complex and multifactorial disease
and although we did not observe NET formation in response to iRBCs, merozoites, the parasite
digestive vacuole or even heme itself in resting unprimed neutrophils, we showed that NETs
are produced in response to malaria associated free heme after TNF priming in a ROS and
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protease activity dependent manner (Fig. 8 & 9). The inflammatory environment in the blood
stream of infected individuals may however favor NET release in response to the other stimuli.
While the term ‘neutrophil priming’ is liberally used throughout the literature and associated
with overall increased performance including enhanced phagocytosis, degranulation and NET
formation, and, contradictory, to the latter enhanced longevity of the cells, the actual underlying
mechanisms are not understood (Condliffe, Kitchen et al. 1998). Interestingly, TNF priming of
neutrophils induces increased levels of H2O2 in the cells, which in cooperation with free heme
might lead to free radical formation (see above). The induction of H2O2 is also observed in the
presence of GCSF, IL-1 and IL-6 (Elbim, Bailly et al. 1994), all of which are induced in malaria
patients and infected mice.
In vitro experiments with neutrophils isolated from CGD patients showed that no NADPH
oxidase activity is required for heme generated NETs. Other stimuli, like silica and the calcium
ionophore A23187 induce NETosis (Brinkmann, Goosmann et al. 2012, Douda, Khan et al.
2015) independently of NOX2 relying, at least partially, on mitochondrial ROS (Douda, Khan
et al. 2015).  In these cases ROS are produced by enzymes of the electron transport chain or
other cellular oxidant enzymes such as xanthine oxidase (Kalogeris, Bao et al. 2014). Our data
show that heme, unlike PMA, relies on alternative sources of ROS and is mechanistically more
similar to NET inducers like microcrystals.
In accordance with previous findings, heme induced NETs require PKC, CDK6 and the
neutrophil specific protease NE. This finding underlines regulated sensing and response as
opposed to secondary necrotic cell death that could also lead to the release of chromatin from
neutrophils. PKC and CDK6 are important regulators of cell activation and proliferation,
respectively (Altman and Kong 2014, Sherr, Beach et al. 2016) and therapeutic or experimental
inhibition of their activity may lead to detrimental effects apart from NETosis inhibition. The
inhibition of the neutrophil specific protease NE and Pr3, on the other hand, is a promising
strategy to inhibit NETosis in human and murine (Fig. 10) neutrophils. As previously suggested
(Kessenbrock,  Dau  et  al.  2011)  we  observed  that  suppression  of  NE  activity  alone  is  not
sufficient  to  abrogate  NETosis  completely  (Fig.  10),  arguing  for  the  necessity  of  a  dual
neutrophil serine protease (NSP) inhibitor for therapeutic approaches in hemolytic diseases. In
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agreement with our results, the neutrophil elastase ‘specific’ inhibitor Sivelestat can reduce the
symptoms in a rat model of sepsis (Suda, Takeuchi et al. 2010, Li, Jia et al. 2016) but not abrogate
them. Interestingly, Sivelestat inhibits Pr3 but to a far lower degree than it inhibits NE, probably
leaving some residual activity. NE and possibly NET formation is a target for several other
diseases such as chronic obstructive pulmonary disease (von Nussbaum and Li 2015) and
Pseudomonas aeruginosa lung infection (Benarafa, Priebe et al. 2007) indicating that discoveries
concerning the pathogenic mode of action of NETs and NSPs could have a general therapeutic
impact.
Although PAD4 has been described as an essential enzyme to release NETs, we showed that
neither inhibition nor genetic deficiency in the PAD4 gene have any effect on either PMA or
heme/TNF mediated NET formation. Indeed, there is a controversy in the field as to whether
PAD4 activity is required for NET formation (Konig and Andrade 2016) or whether it is a
mechanism by which protein function on the released structure can be altered. Our data points
towards a non-essential role of protein deimination, however PAD4 requirement was initially
described for LPS induced NETs (Li, Li et al. 2010) and might just be specific to certain stimuli.
There appear to be several paths leading to NETosis.
DISCUSSION 69
9 NET components drive cytoadherence and inflammatory
pathogenesis
9.1 P. chabaudi malaria
The second part of this thesis utilizes the Plasmodium chabaudi mouse model to address the
mechanism by which neutrophils provoke organ damage of a blood borne hemolytic infection.
As mentioned before, we chose the P. chabaudi mouse model for two main reasons: First, The
human pathogenic Plasmodia are synchronous, meaning that development in the infected
RBCs happens all at the same time throughout the entire host. This has important implications
since it leads to synchronous iRBCs sequestration in the microvasculature of afflicted organs
leading to high local parasite load. Furthermore, synchronous rupture of iRBCs leads to a
sudden and drastic surge in local PAMPs and DAMPs and subsequently cytokine concentration
(Autino, Corbett et al. 2012, Gazzinelli, Kalantari et al. 2014). P. chabaudi has a synchronous
replication cycle, while other mouse parasites strains such as P. berghei ANKA and P. yoelii do
not.
Second, human severe disease and tissue damage are associated with sequestration of infected
red blood cells into the deep bed vasculature of afflicted organs (Autino, Corbett et al. 2012).
This sequestration depends on parasite receptors such as the infamous PfEMP1 and host
adhesion molecules such as CD36, ICAM-1 and EPCR (Chakravorty and Craig 2005, Turner,
Lavstsen et al. 2013). While P. berghei ANKA is the model of choice to investigate cerebral
malaria, the most prominent form of severe malaria, P. berghei does not sequester and shows
no binding to endothelial cells via surface adhesion molecules. We aimed to study neutrophils
and their externalized components in the development of cytoadherence mediated tissue
damage. In the P. chabaudi mouse model the involvement of neutrophils (Rocha, Marques et
al. 2015) as well as ICAM-1 (Cunningham, Lin et al. 2017) are established, making it our model
of choice.
The in vitro experiment shown in figure 10 allowed us to choose the appropriate mouse
genotypes to address the two following questions. First, NE/Pr3 deficient mice are unable to
produce NETs and allow us to test whether they are relevant in malaria. Second, DNase 1
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deficient mice release NETs but do not degrade the macrostructure and therefore allow us to
answer the question whether pathogenic effects of NETs are mediated by the large intact
structure or by the release and dissemination of individual components.
9.2 The mechanism of NET component mediated tissue damage
In this study we show that NETs are formed in the circulation of P. chabaudi infected mice and
lead  to  (1)  the  induction  of  emergency  granulopoiesis  via  the  generation  of  GCSF,  (2)  the
upregulation of the endothelial adhesion markers ICAM-1 and EPCR thereby facilitating (3)
parasite cytoadhesion and (4) neutrophil influx in the liver which ultimately lead to (5) liver
damage. Prevention of NET formation in animals were NE and Pr3 are deleted abrogates the
entire process. Furthermore, we demonstrate that these mechanisms of pathogenesis rely on
the systemic dissemination of individual NET components as they are also abrogated in mice
still capable of forming NETs but unable to digest NET structures in circulation (Fig. 11 – 18).
Our findings underline that there are different mechanisms by which systemically produced
NETs lead to adverse effects to the host. In direct contrast to what we observe in P. chabaudi
infected mice, others showed that the application of recombinant DNase 1 can be advantageous
in diseases linked to NET formation. The autoantibody-driven pathology of systemic lupus
erythematosus  for  example  is  propagated  by  a  decrease  in  DNase  1  activity  in  the  plasma
(Hakkim, Furnrohr et al. 2010) suggesting systemic DNase 1 application as a potential
treatment. Moreover, the failure to degrade NETs in small vessels induce thrombosis and tissues
damage in several mouse models of vascular occlusion (Brill, Fuchs et al. 2012, Jimenez-Alcazar,
Napirei et al. 2015). Lastly local DNase 1 application prevents tissue damage in the lung of both
LPS treated animals (Liu, Su et al. 2016) and in an acute lung injury model of malaria (Sercundes,
Ortolan et al. 2016). Contrary to these studies and in accordance with our findings Dnase 1 is
detrimental in a cecal ligation and puncture model of sepsis. Administration of the recombinant
enzyme to septic animals decreases survival and increases inflammatory cytokines and tissue
damage and neutrophil infiltration in livers and lungs (Meng, Paunel-Gorgulu et al. 2012).
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It seems that comparable to human disease, the pathogenic event in the P. chabaudi model is
the sequestration of the parasite into the microvasculature of afflicted organs. This mechanism
does not play a role in sterile pathogenic conditions such as SLE and deep vein thrombosis,
which might explain the drastically different roles DNase 1 seems to play under different
conditions. Additionally, local application of DNase 1 by inhalation restricts the effect of the
enzyme to NET structures occurring in the actual tissue of the organ thus showing a beneficial
effect (Liu, Su et al. 2016, Sercundes, Ortolan et al. 2016). Such a local application is not possible
in internal organs such as the liver, kidneys, spleen and brain which are afflicted during a
systemic Plasmodium infection in the human host. Unfortunately, neither of the groups
measured the impact such a local administration of DNase 1 had on the systemic levels of either
NETs or neutrophil components such as NE, Pr3, MPO and lipocalin that are associated with
severe disease in humans. The lack of this information makes speculations about differences
and/or similarities between the studies almost impossible.
Neutrophil proteases regulate or induce inflammation and inflammatory tissue damage in
multiple ways in addition to being imperative for NET formation (Fig. 10 and Fig. 11).
Unfortunately,  we  can  only  speculate  on  the  effects  of  these  proteases  in  malaria  since  our
experiments cannot establish a direct causal relationship between individual protease functions
and disease progression. Indeed, the lack of tissue damage and cytokine release in uninfected
mice injected with sonicated NETs (Fig. 15) argues for a multifactorial pathogenic mechanism,
where infectious agents (PAMPs) and host response (DAMPs) contribute. Notably, Sivelestat
treatment of NETs prior to injection into infected mice abrogated the adverse effects arguing
for a role of neutrophil protease activity.
9.2.1 Neutrophil proteases and cytokines
In addition to regulating NETosis the neutrophil proteases are implicated in the intracellular
regulation of IL-1β, as an alternative to the inflammasome in a caspase 1 independent manner
(Netea, van de Veerdonk et al. 2015). We can exclude a role of such intracellular regulatory
mechanisms based on the NET injection experiments describe in figure 15.
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Extracellular neutrophil proteases can process cytokines to alter their activity (Clancy, Henry
et al. 2017). This mechanism can either in- or decrease cytokine activity. For example,
neutrophil proteases activate IL-8 through N-terminal cleavage (Shpacovitch, Feld et al. 2008)
in humans. Although mice do not have IL-8, the aspect of cytokine activity modulation during
a malaria infection might be an interesting topic to address in the P. chabaudi mouse model in
the future. Interestingly, older studies suggest that neutrophil proteases generate a more active
form of TNF (Kriegler, Perez et al. 1988). We observed that TNF escalates the inflammatory
response by inducing NETosis together with heme. In addition, TNF activates the endothelium
to upregulate cell adhesion markers such as ICAM-1 (Burke-Gaffney and Hellewell 1996, Chan,
Shum et al. 2008). Although we have not addressed the effect of TNF in our model, ICAM-1 is
vital for both parasite and immune cell sequestration. NET associated NE can also lead to the
activation of IL-1α (Clancy, Henry et al. 2017) and this might, in an autocrine manner, lead to
more  production  of  the  cytokine  itself  leading  once  again  to  a  positive  feed-forward  loop.
Absence of autocrine cytokine stimulation might explain the absence of many proinflammatory
cytokines in the NET production and dissemination deficient genotypes (Fig. 14).
Interestingly so far, the role of NETs or their components in GCSF production and emergency
granulopoiesis has not been described. We do demonstrate such a mechanism but only in the
context of infection once again emphasizing the interplay between PAMPs and DAMPs.
9.2.2 NET components and adhesion molecules
NE upregulates the expression of ICAM-1 on endothelial cells directly (Ishihara, Yamaguchi et
al. 2006) or, as described above, indirectly by regulating cytokine activity and expression. This
is in accordance with our findings that ICAM-1 upregulation is decreased on the endothelium
of infected animals deficient in NET production and processing (Fig. 16).
We also observe increased levels of soluble ICAM-1 (sICAM-1) and interestingly EPCR. It is
possible that the upregulation of cell bound ICAM-1 binds to neutrophils (discussed below)
and that these cells as well as extracellular neutrophil proteases cleave both ICAM and EPCR
on the endothelial cell surface. At first glance, this appears to have a favorable effect since we
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propose that it decreases binding of iRBCs, neutrophils and other immune cells. Moreover
sICAM-1 decreases the adhesion capacity of neutrophils when binding to circulating cells
(Spark, Scott et al. 1999), although this effect is debated and some scientists argue that sICAM-
1  might  be  a  shedding  product  and  a  marker  for  the  upregulation  of  cell-bound  ICAM-1
(Witkowska and Borawska 2004).
Whilst it is well established that cell bound EPCR is cytoprotective and negatively regulates the
coagulation cascade and formation of thrombi by activating protein C (Mohan Rao, Esmon et
al. 2014), the role of soluble EPCR (sEPCR) is less well understood. sEPCR binds APC blocking
its activity propagating coagulation. Interestingly, a recent study shows that APC inhibits NET
formation (Healy, Puy et al. 2017). The release of sEPCR in infected animals might lead to more
NET formation in circulation aggravating the disease.
Lastly, several studies report direct induction of endothelial cell death by NET structures (Gupta,
Joshi et al. 2010, Saffarzadeh, Juenemann et al. 2012, Meegan, Yang et al. 2017) which leads to
vascular leakage and expose the underlying tissue to molecules present in circulation,
suggesting another link between NETs and malaria pathogenic principles.
9.2.3 NET components and immune cell recruitment
Once NE and Pr3 are released from cells, either by degranulation or bound to NETs, they can
degrade extracellular matrix proteins such as elastin, fibronectin and collagen (Mainardi, Hasty
et al. 1980, McDonald and Kelley 1980, McGowan and Murray 1987) promoting tissue
permeability and facilitating immune cell infiltration. This mechanism becomes especially
relevant in the context of endothelial cell apoptosis. We observed neutrophil recruitment to the
liver of infected mice which is absent in both the N/Pr3 and DNase deficient genotypes,
although we cannot assess whether these cells left the vasculature and entered the underlying
tissue (Fig. 13). It is also not possible to gage whether neutrophil recruitment to the liver is cause
or effect of the damage to hepatocytes and whether other cell types might be involved.
In the P. berghei model of cerebral malaria several other cell types are involved in pathogenesis.
Monocytes and/or macrophages accumulate in the brain of these animals (Srivastava, Field et
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al. 2010). Neutrophil products attract monocytes to sites of infection either by modulating the
cytokine environment (see above) or by releasing granular proteins through degranulation and
NETosis (Soehnlein, Lindbom et al. 2009) and these activated monocytes might contribute to
endothelial dysfunction by the release of ROS (Woller, Brandt et al. 2008). The accumulation
of monocytes in afflicted organs also occurs in human patients (Dorovini-Zis, Schmidt et al.
2011) and might represent a translatable phenomenon to address in our model.
T-cells have a controversial role in the pathology of human diseases. Both CD4+ and CD8+ T-
cells are required to develop experimental cerebral malaria (ECM). Potentially CD4+ cells
prime CD8+ cells to carry out detrimental functions (Belnoue, Kayibanda et al. 2002). In
addition, and in agreement with our findings that mere injection of NETs into uninfected mice
does not cause pathology, adoptive transfer of CD8+ cells from infected to naive mice does not
cause pathology (Nitcheu, Bonduelle et al. 2003). The controversy, however, stems from the fact
that to this date no CD8+ Tcell involvement in human disease has been demonstrated, not even
in post mortem histological studies. T-cells accumulate in the livers of infected mice and are
essential for pathology as revealed by lack of organ damage in Rag -/- mice (Brugat,
Cunningham et al. 2014). It will be interesting to test if T-cell recruitment is also dependent on
neutrophil proteases.
9.3 Intervention strategies
In severe malaria anti-parasite therapy often fails to save patients (Varo, Crowley et al. 2018)
highlighting the need for adjunctive therapies. Indeed, a wide range of immunomodulatory
therapies were tested (Varo, Crowley et al. 2018). So far, none were sufficiently protective and
the need for novel approaches remains. Our study suggests several potential targets of
intervention.
Inhibition of NE/Pr3 to improve disease outcome in several infectious and non-infectious
diseases is a well-established idea (Kaneko, Kudoh et al. 1997) and has already been shown to
be partially effective in a malaria model (Sercundes, Ortolan et al. 2016). Our data confirms that
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a pan-neutrophil serine protease inhibitor might be beneficial. The development of such a drug
is an avenue worth exploring.
To prevent NET formation in malaria patients, it might be relevant to apply hemopexin, which
was shown to work in other hemolytic conditions (Chen, Zhang et al. 2014). Furthermore, our
data suggest that this therapeutic approach might have an especially beneficial effect when
combined with anti-TNF therapy (Varo, Crowley et al. 2018).
As mentioned above to prevent NETosis an anti-sEPCR therapy is a possibility that might
reduce the coagulatory potential and inhibit systemic NETosis by the release of the NET
inhibitor APC (Healy, Puy et al. 2017). While antibodies against sEPCR exist (as used in the
ELISA) and could be used to inhibit its activity, antibody therapy is hardly a viable approach to
treat malaria (see below). It would therefore be of interest to develop small molecule inhibitors
that can selectively act on either cell bound or soluble EPCR. Another approach might be to
inhibit the shedding of EPCR from the endothelial surface by Withaferin (Ku, Han et al. 2014).
The effects of such a treatment might be ambiguous, and might decrease NETosis but increase
parasite and neutrophil adhesion.
We observe beneficial effects of anti-GCSF antibody therapy in infected mice, which might
represent a powerful way to suppress emergency granulopoiesis that allows a sustained
inflammatory environment including NETosis, cytokine release and endothelial activation.
Unfortunately, there is currently no anti-GCSF antibody therapy available in patients and the
development  of  such  therapeutic  agents  is  a  long  and  difficult  road.  There  are  two  major
problems with antibody therapies that apply specially to developing countries: Firstly, while
some forms of cancer are treated by antibody therapies in developed countries (Willems,
Gauger et al. 2005), these therapies are expensive and unusable to control a disease that is
associated with poverty. Secondly, antibodies must be applied intravenously and while this can
and is done in malaria patients suffering from severe disease in urban hospitals, it is not
practical in remote rural regions.
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10 Translation of our findings to human disease
The  observation  that  people  of  African  origin  and  a  few  groups  from  the  Middle  East  are
neutropenic in homeostasis is in agreement with a detrimental role of neutrophils in malaria
infections (Thobakgale and Ndung'u 2014).  This condition is known as ethnic or benign
neutropenia. Moreover, this condition is directly linked to single nucleotide polymorphisms in
CDK6  and  GCSF  (Reiner,  Lettre  et  al.  2011),  which  are  directly  involved  in  the  NET  and
hematopoiesis driven mechanism of pathology we describe here. It is plausible that gene
variants that promote tolerance to malaria are selected in endemic regions because this disease
has exerted evolutionary selective pressure on human populations.
Similarly to what we observe in P. chabaudi infected mice, neutrophilia is common in patients
suffering from P. falciparum (Maina, Walsh et al. 2010) and P. vivax (Rocha, Marques et al.
2015) infection and these increased neutrophil counts can be linked to symptoms of severe
malaria (Squire, Asmah et al. 2016). As shown by us and others malaria is accompanied by
elevated GCSF levels (Stoiser, Looareesuwan et al. 2000), suggesting a potential to translate the
therapeutic success shown in Figure 17 to human disease.
Interestingly the role of endothelial adhesion molecules such as ICAM-1 (Chakravorty and
Craig 2005, Cunningham, Lin et al. 2017) and EPCR (Turner, Lavstsen et al. 2013, Kessler,
Dankwa et al. 2017) are conserved between human and mouse making our findings translatable
to human disease. This opens a future line of investigation as discussed below.
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11 Conclusions and Outlook
During this study, we demonstrated that NETs are formed in the circulation of humans and
mice infected with Plasmodium spp. We identified TNF and extracellular heme as stimuli for
this intravascular NET formation and observed a positive correlation between the amount of
extracellular heme and extracellular NETs in human patients.
In the P. chabaudi model of malaria, we demonstrated that NETs are released over the course
of the infection and are digested by Dnase 1 leading to the systemic dissemination of active NET
components. These propagate a proinflammatory environment by inducing cytokine
production and emergency granulopoiesis, activating the endothelium to express adhesion
markers and thereby mediating the sequestration of infected red blood cells and neutrophils to
the microvasculature of the liver. In conclusion, we showed that activated neutrophils
perpetuate an inflammatory feed forward loop that leads to malaria associated organ damage
(Fig. 19).
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Fig.19: Graphic representation of the mechanism of neutrophil induced malaria pathogenesis. NETs are
induced in circulation, digested by DNase 1and subsequently lead to the production of G-CSF and the upregulation
of endothelial surface marker ICAM-1 and EPCR. This combination leads to neutrophilia and neutrophil and
parasite sequestration into the liver
Future research should focus on the mechanism by which neutrophil components lead to
endothelial activation since it might have therapeutic implications that extend beyond malaria
and might be useful in the treatment of other hemolytic disease such as sepsis and sickle cell
disease. It is important to identify what part of the NETs contributes to what degree to
endothelial activation. It is also crucial to identify how these factors are sensed by endothelial
cells, which intracellular signaling pathways are activated and exactly what array of surface
molecules are upregulated in response to NET components. We observed that the inhibition of
protease activity decreases the capacity of NETs to reconstitute pathology but the mechanism
remains elusive. It would be an interesting initial experiment to inject proteases by themselves
into infected NET deficient mice and monitor disease progression.
Finally, these findings should be taken to other fields of research where NETs and their
interaction with endothelial cells might play a detrimental role such as sepsis, SLE and ischemic
stroke. If we could prevent the uncontrolled activation of the endothelium by dying neutrophils
this would hand us a mighty therapeutic tool.
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MATERIALS & METHODS
12 Materials
12.1 Buffers and solutions
Casein solution 10X PBS, 9% (w/v) casein
ELISA general sample
diluent
1% BSA in PBS-T
ELISA wash buffer 0.05 % Tween in PBS
FACS buffer PBS, 2.5 % FCS, 0.1 %NaN3
Human NET assay media RPMI 1640, 10mM HEPES buffer, 0.05 % (v/v) Human serum albumin
Microscopy blocking
buffer
PBS, 5 % (v/v) normal donkey serum. 15 % (v/v) Cold water fish gelatin, 1 % (w/v)
bovine serum albumin, 0.05 % (v/v) Tween 20
Mouse NET assay media RPMI 1640, 1% plasma from DNase k.o. mice,
Neutrophil preparation
wash buffer
PBS, 0.05 % (v/v) human serum albumin
P. falciparum complete
growth medium
RPMI (500 ml: 10.4 g RPMI, 5.95 g HEPES (25mM), 0.05 g hypoxanthine)
Add: 25 ml Albumax II (10% in ddH2O)
         15 ml Sodium Bicarbonate (7% in ddH2O)
          0.1 ml Gentamicin (50mg/ml)
Peritoneal lavage
solution
PBS, 0.02 % (v/v) EDTA
Posphate buffered saline
(PBS)
137 mM NaCl, 2.7 mM KCl, 4.3 mM NA2PO4, 1.47 ,; KH2PO4
Bone marrow derived
macrophage medium
DMEM + 10 % (v/v) FCS, 20 % (v/v) L929 cell conditioned supernatant, 1 % (v/v)
L-glutamine, antibiotics to liking
Buffer A 10 mM HEPES, 10 mM KCl, 3 mM NaCl. 3 mM MgCl2, 1 mM EDTA, 1mM EGTA,
2 mM dithiothreitol
2 mM phenylmethylsulfonyl fluoride
100 µg/ml soybean trypsin inhibitor
1 mM benzamidine
2 mM levamisole
1 mM NA3VO4
10 mM NAF
20 mM glycerophospaht
60 µl/5 x 106 cells inhibitor mixture (Sigma P-8340)
Buffer NE 20 mM HEPES, 25 % glycerol, 0.8 , KCL, 1mM MgCl2, 1% Nonidet P-40, 0.5 mM
EDTA, 2mM dithiothreitol
+ inhibitors as in buffer A
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12.2 Cell culture reagents
Reagent Product Number Manufacturer
Heparin natrium H-NA-25000 Ratiopharm
Histopaque 11191 Sigma-Aldrich
Percoll 17-0891-01 GE Healthcare
RPMI 12633020 Gibco
Fetal calf serum 12003C Sigma-Aldrich
G7513 Sigma-Aldrich
Penicillin/Streptomycin P4333 Sigma-Aldrich
HEPES H0887 Sigma-Aldrich
PMA P 8139 Sigma-Aldrich
Albunorm 20 % 200271
Murine G-CSF 2505 PEPROTECH
Murine TNF 315-01A PEPROTECH
Human TNF 300-01A PEPROTECH
Heme (Hemin) H651-9 Frontier Scientific
Inhibitor Target Chemical name Concentration Manufacturer
Go6976 PKC
5,6,7,13-Tetrahydro-13-methyl-5-oxo-
12H-indolo[2,3-a]pyrrolo[3,4-
c]carbazole-12-propanenitrile
10 μM Tocris
Pyrocatechol ROSscavenger 1,2-Dihydroxybenzene 30 μM Sigma-Aldrich
Cycloheximid
e translation
3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-
hydroxyethyl]glutarimide 1 μg/ml Sigma-Aldrich
LY2835219 CDK4/6 1 μM Selleck
TDFA PAD4
N-Acetyl-L-threonyl-L-α-aspartyl-N5-(2-
fluoro-1-iminoethyl)-L-ornithinamide
trifluoroacetate
200 μM Tocris
GW311616A NE
(3S,3aS,6aR)-3-Isopropyl-1-
(methanesulfonyl)-4-[4-(1-piperidinyl)-
2(E)-
butenoyl]perhydropyrrolo[3,2b]pyrrol-
2(1H)-one hydrochloride
20 μM Sigma-Aldrich
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12.3 ELISA and bioplex kits
Reagent Product Name Manufacturer
Elastase, Human, ELISA kit HK319-02 Hycult Biotech
Cell Death Detection ELISA Plus 11920685001 Roche Diagnostics
Human Interleukin 8 Quantikine
ELISA
S8000C R&D Systems
Mouse Neutrophil Elastase Duo
Set ELISA
DY4517-05 R&D Systems
Mouse G-CSF Quantikine ELISA
Kit
MCS00 R&D Systems
Human  G-CSF Quantikine ELISa
Kit
SC S50 R&D Systems
Bio-Plex  Pro  Mouse  Cytokine  23-
plex Assay
M50-MSDS BIORAD
Mouse ICAM-1 /CD54 Quantikine
ELISA Kit
MIC100 R&D Systems
Mouse EPCR ELISA Kit LS-F3979 LifeSpan BioSciences, Inc.
12.4 Antibodies & Dyes
Target Product Name Manufacturer Assay
Biotin-anti-NE Ab79962 abcam NET ELISA
Anti-neutrophil elastase 481001 Calbiochem IFA of cells
ICAM goat polyclonal antibody AF796 Novus Biologicals IFA of tissue
VCAM goat polyclonal antibody AF643 Novus Biologicals IFA of tissue
Calgranulin A [8A6a] rat
monoclonal AB
MPIIB (Robert Hurwitz) IFA of tissue
Hoechst33342 639 ImmunoChemistry IFA of cells/tissue
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13Methods
13.1 Donor consent
Donors gave consent to blood drawing in accordance with the Helsinki Declaration. All patients
or their parents in the case of children gave informed consent to the blood donation. The blood
samples were collected with approval from the ethical committees responsible for each
institution.
13.2 Human cell isolation and sample preparation
13.2.1 Human neutrophil isolation
Human neutrophils were isolated by two subsequent density gradient separations as has been
established in the field (Fuchs, Abed et al. 2007). Blood was collected into EDTA KE containing
tubes (monovette system) and subsequently layered onto an equal volume of Histopaque 1119
and centrifuged at 800 x g for 20 minutes with acceleration and brakes set at 7 and 3, respectively.
The PBMC layer was then discarded and the neutrophil-rich layer collected, washed with
neutrophil preparation wash buffer and pelleted by centrifugation at 300 x g for 10 minutes,
acceleration and brakes set at 9. The resulting pellet was resuspended in 2 ml wash buffer and
layered onto a discontinuous PBS-buffered Percoll gradient (85%, 80%, 75%, 70%, 65% in 2ml
layers). The preparation was again centrifuged at 800 x g for 20 minutes with acceleration and
brakes set to 7 and 3. The lower neutrophil band was collected, washed and resuspended in
wash buffer. Cell concentration was determined using either a CASY cell counter or a Neubauer
chamber. Neutrophils were further processed as soon as possible after isolation.
13.2.2 Human plasma preparation
Plasma from human malaria patients and healthy control donors was obtained from venous
blood  collected  into  EDTA  KE  containing  monovette  system  tubes.  1  ml  of  blood  was
transferred to low-bind 1.5 ml Eppendorf and centrifuged at 10,000 x g at 4°C for 10 minutes.
Plasma samples were snap frozen in liquid nitrogen until further use. Samples were always
thawed on ice.
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13.2.3 P. falciparum in vitro culture
The red blood cells necessary for P. falciparum culture were generated from the pelleted RBCs
in the first step of the standard neutrophil isolation procedure. They were washed and
resuspended to 50 % hematocrit in RPMI and stored at 4°C for up to two weeks.
Frozen parasites were removed from the freezer and thawed at room temperature, the 550 µl
aliquot was transferred to a 50 ml Falcon tube. Very slowly and under constant agitation 5-7
drops of 12 % NaCl were added to the parasites and they were left standing at room temperature
for five minutes. Afterwards 4.5 ml of 1.65 % NaCl were added at constant agitation and cells
were incubated for five minutes at room temperature. Cells were pelleted by centrifugation at
3000  rpm  for  four  minutes  and  washed  with  4.5  ml  0.9  %  NaCl/  0.2  %  Dextrose  and  then
pelleted again. Then cells were resuspended in 5 ml culture medium and 300 µl red blood cells
at 50 % hematocrit were added. Cluture flask was gased (to reach 5 % O2) and placed at 37°C.
P. falciparum was grown at 5% hematocrit at 5 % O2 and cultures were generally maintained at
a parasitemia below 20%.
13.2.4 P. falciparum infected red blood cell isolation
The mature-stage P. falciparum culture was washed and taken up in 2 ml of RPMI at up to 50%
hematocrit, which were then layered onto 5 ml of a 60% Percoll solution. The mixture was
centrifuged at 2000 x g at room temperature for 20 minutes with acceleration and brake set to
7 and 0, respectively. The trophozoites were collected at the interphase between RPMI and
Percoll, while uninfected RBCs and ring stage infected RBCs were pelleted. Parasites were
washed three times with RPMI and iRBCs were pelleted at 1500 rpm at room temperature for
3 minutes.
13.2.5 Free merozoite preparation
After enrichment the trophozoite infected red blood cells were pelleted once more and take up
in  60  µl  0.03  %  saponin  solution  and  kept  on  ice  for  5  min.  Subsequently  the  sample  was
centrifuged at 16,000 x g at 4°C for 15 minutes, washed three times with PBS and taken up in
100 µl RPMI. Concentration of merozoites was determined by use of a Neubauer chamber.
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13.3 Animal experiments
13.3.1 Ethics approval
Animal experiments are in compliance with the German animal protection law and have been
officially approved by the Landesamt für Gesundheit und Soziales, Berlin.
13.3.2 Mouse neutrophil isolation
Murine neutrophils were isolated as described previously (Swamydas, Luo et al. 2015). Mice
were injected once in the evening and once in the morning of the following day with 1 ml of 9%
sterile casein solution. Three hours after the second injection mice were euthanized and the
peritoneum  was  lavaged  with  5  ml  peritoneal  lavage  solution.  The  cells  were  subsequently
pelleted by centrifugation at 200 x g for 10 minutes at room temperature and washed twice with
PBS. Finally the pellet from each mouse was resuspended in 1 ml PBS and layered onto a 90%
Percoll solution at room temperature in a 10-ml Beckman ultracentrifuge tube. The mixture
was then spun for 20 minutes at 60,650 x g at 4°C. Neutrophils can subsequently be collected
from the second opaque layer of the gradient, washed and used as soon as possible for
experimental procedures.
13.3.3 P. chabaudi infection, plasma and organ preparation of WT, NE/Pr3 and
DNase deficient mice
Mice of all genotypes were infected by injection of 1x104 viable parasites i.v.. To ensure viability
of the parasites a frozen stabilite was thawed and injected i.p. into a transfer mouse. Parasitemia
of that mouse was monitored from day 3 after stabilite injection onward. Once the parasitemia
had reached between 1 – 10% the amount of iRBCs/µl blood was calculated as:
A = % parasitemia x 7 x 106
This allowed us to calculate the amount of blood needed to be diluted in 200 µl of PBS to achieve
a suspension containing 1x104 iRBCs/200 µl. The volume injected into each mouse was adjust
according to body weight so that every animal received 1x104 iRBCs per 20 g.
Parasitemia of infected mice was monitored from day 5 post infection onward every 48 hours
by thin blood smear. On the prior established days post infection mice were bleed by cardiac
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puncture under deep isoflurane anesthesia, leading to painless death by blood loss. Afterwards
organs were harvested and fixed for 20h at room temperature in 2% PFA. The blood was kept
from coagulating by addition of 50µM final concentration of EDTA and blood was kept on ice
immediately after preparation. Plasma was generated by centrifugation at 10,000 x g at 4°C for
10 minutes. Plasma was aliquoted, frozen in liquid nitrogen and stored at -80°C until further
use. Plasma was always thawed on ice.
13.3.4 Determination of liver enzyme concentration in mouse plasma
The concentrations of the hepatocyte specific enzymes alanine-aminotransferase and aspartate-
aminotransferase in the plasma of experimental animals were determined by the routine
veterinarian service laboratory at SYNLAB.vet GmbH (Turmstraße 21, 10559 Berlin).
13.3.5 FACS analysis of mouse whole blood
After samples were spun down to collect plasma the cell pellet was resuspended to a volume
equivalent to the collection volume. 100 µl of the sample were transferred to a FACS tube and
stained with an equivalent 100 µl of FACS antibody diluted 1:100 in FACS buffer and incubate
for 30 minutes at room temperature protected from light. Afterwards 3 ml of 1X FixLyse
solution (Invitrogen 00-5333-54) was added to the samples and they were incubated for 60
minutes at room temperature protected from light. Samples were spun down at 300 x g at room
temperature for 10 min and washed at least twice. Data was collected on a MACS Quant
Analyzer after appropriate compensations between channels and analyzed using FlowJo
software.
13.4 NET formation assay
13.4.1 Culture and stimulation of neutrophils
To be able to perform immunofluorescence staining, 24 well plates were prepared by adding
glass  cover slips  to the bottom of  each well.  For the NETosis  assays,  1x105 neutrophils were
added directly  into 500 µl  of  NET assay medium for each well  of  a  24 well  plate.  In case of
inhibitor experiments the medium already contained the appropriate inhibitor and the cells
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were incubated for 30 minutes at 37°C. Afterwards TNF was added and cells were incubated for
another 15 minutes. Afterwards 500 µl medium containing inhibitor, TNF and the appropriate
stimulus (at 2X) was added to each well. TNF was used at 2 ng/ml, PMA at 50 nM and heme at
20 µM is not indicated differently. All reagents were freshly prepared on the day of the
experiment.
Human neutrophils were fixed after three hours of stimulation.
Murine neutrophils were fixed after 18 – 20 hours of stimulation.
13.4.2 Quantification of NET formation
The quantification of NETosis was carried out as described here (Brinkmann, Goosmann et al.
2012). Briefly, cells were fixed for 30 minutes at room temperature in 2 % paraformaldehyde
(PFA) post NET induction, permeabilized with 0.5 % Triton-X100 and blocked for 30 minutes
in blocking buffer. Cells were then stained with the anti-neutrophil elastase antibody (see above)
and antibody directed against the subnucleosomal complex of Histone 2A, Histone 2B and
chromatin (Losman, Fasy et al. 1992). The secondary antibodies goat anti-mouse Alexa Fluor
568 and goat anti-rabbit Alexa Fluor 488 as well as Hoechst 33342 (Sigma-Aldrich) were used.
Samples were mounted on coverslips with Mowiol. Image acquisition was done using a Leica
DMR upright fluorescence microscope equipped with a Jenoptic B/W digital microscope
camera and analyzed using ImageJ/FIJI software.
13.5 Sample preparation for reinjection experiments
NETs (sonicated and DNase treated): Murine NETs were prepared as described above, washed
to remove residual PMA, scraped from the plate and sonicated. Subsequently the DNA content
was quantified by PicoGreen assay as described below. Where applicable sample was then
treated with 2 U DNase 1 overnight at 37°C. Complete digestion of DNA was confirmed both
by agarose gel and PicoGreen measurement.
NETs (Sivelestat treated): These samples were prepared as described above but Sivelestat was
added two hours before dedicated harvest time and subsequently washed away before NETs
were scraped from the plate.
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Chromatin from bone marrow derived macrophages: bone marrow derived macrophages were
thawed from frozen stock by carefully placing the vials in a 37°C water bath. Once thawed the
cells were transferred to a 50 ml Falcon tube and 10 ml culture medium was added dropwise.
Cells were then transferred to a tissue culture plate, the medium was changed after 4 hours to
remove residual DMSO and non-adherent dead cells.
When cells were confluent and ready to be harvested, medium was removed and 5 ml cold (4°C)
PBS was added. The petri dishes were then placed at 4°C for 15-30 minutes before they were
washed off the plate with a pipette. Cells were then washed and counted, per 5 x 106 cells 300 µl
of  hypotonic  buffer  A  was  added  and  incubated  on  ice  for  15  minutes.  Subsequently  0.05
volumes of 10 % Nonidet P-40 were added, the cells were vortexed and centrifuged at 500 x g
for 10 minutes at 4°C. The supernatant was discarded, the nuclei in the pellet washed in buffer
A and subsequently resuspended in 50 µl of ice-cold buffer NE. Following a 20 minutes
incubation on ice with occasional mixing the samples were centrifuged at 14,000 x g for 15
minutes at 4°C. The supernatant was discarded and the pellet containing the chromatin
resuspended in ddH2O. Chromatin concentration was determined by picogreen assay and
samples were stored at -80°C.
13.6 Oxidative burst chemiluminescence assay
ROS production was measured by luminol chemiluminescence. Horse reddish peroxidase
catalyzes the oxidation of luminol by hydrogen peroxide generated by the respiratory burst,
which generates a quantifiable signal when measured in a luminometer. Neutrophils were
seeded in a 96-well plate at 1x105 cells per well in 100 µl of NET assay media supplemented with
50 µM luminol and 1.2 units/ml HRP (both from Sigma Aldrich). Cells were incubated 30 min
at 37°C and afterwards stimulated by addition of 100 µl of 2X solutions of the indicated stimuli.
Luminescence  was  measured  over  the  indicated  period  of  time  in  a  VICTOR  Light
luminescence counter (Perkin Elmer).
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13.7 Quantification of total heme – formic acid assay
To make heme standard curve, the heme stock used for cell culture experiments was diluted in
ddH2O. The top standard was 16 µM, followed by a 1:2 serial dilution. Plasma samples were
diluted 1:50 in ddH2O. In a 96 well flat bottom plate, 50 µl of each standard and sample were
added per well, followed by addition of 50 µl formic acid (Sigma Aldrich). Both heme stock,
standard and subsequently the plate were protected from light. The absorbance was read at 405
nm and the background was subtracted at 490 nm.
13.8 Quantification of DNA – picogreen assay
The Quant-iT ™ PicoGreen ® dsDNA quantification kit was used to determine the concentration
of dsDNA in solutions containing in vitro generated NETs according to manufacturer’s
instructions. In brief samples were diluted in supplied TE buffer and 100 µl of standards and
samples were plated in a white 96 well flat bottom plate. Samples were normally diluted 1:20,
1:200 and 1:2000 because too much material can saturate the signal. The Quant-iT ™ PicoGreen
® reagent was diluted 1:200 and 100 µl were added to each well (resulting in a 1:400 dilution of
the reagent). Plates were incubate for 2-5 minutes protected from light and fluorescence was
detected using a Fluoroscan plate reader.
13.9 Enzyme linked immunosorbent assays (ELISAs)
13.9.1 General ELISA protocol
ELISAs are used to quantify protein concentrations based on an antibody binding specificity.
In a sandwich ELISA one antibody is used to capture the protein of interest and immobilize it
on the well. A secondary antibody recognizing a different epitope of the same (or a different)
protein is used to detect the protein of interest. The secondary antibody is normally labelled
with biotin, allowing for detection with streptavidin-HRP, which converts a quantitative
colorimetric substrate.
If ELISA kits were used the assay was performed as to manufacturers specifications.
For R&D ELISAs the assay was performed as follows. Plates were coated with capture antibody
over night at room temperature, washed 4 times with general ELISA wash buffer, and blocked
MATERIALS & METHODS 89
with 1% BSA for at least two hours at room temperature. 100 µl of diluted sample was added,
the dilution factor for each assay has to be determined individually, as they can vary greatly
depending on the analyte. Samples were incubated for two hours at room temperature and
plates were washed 4 times. Detection antibody was added and plates were incubated for two
hours at room temperature. Plates were then washed, incubated with streptavidin-HRP, washed
again and incubated with substrate. Substrate development was stopped by acid stop and
measured in a Spectramax M5 microplate reader (Molecular Devices). Data was analyzed either
using SoftMax® Pro software or using excel and www.myassay.com to generate a standard curve.
13.9.2 Human NET ELISA
To detect NETs in the plasma of human malaria patients and healthy control donors the
following assay was used.
Human neutrophils were induced to make NETs in vitro (see below) by PMA stimulation
overnight and scraped from the plate the following morning. The sample was sonicated and the
DNA content measured by picogreen assay (see below) and the samples were adjusted to 1
µg/ml as highest standard for the standard curve. The curve was generated by 1:2 serial dilution
of that top standard.
Samples and standard were diluted in general sample diluent and 50 µl was added to the
precoated anti-NE plate of the Human anti-NE Hycult ELISA kit, followed by two hours
incubation at room temperature with agitation at 350 rpm. The plate was washed 4 times and
50 µl of the anti-DNA-POD diluted 1:100 in its supplied dilution buffer was added for two hours
at room temperature with agitation at 350 rpm. Plates were washed again five times and
subsequently developed with ABTS substrate supplied with the Cell Death Detection ELISA kit.
Plates were stopped and measured in a microplate reader.
13.9.3 Mouse NET ELISA
To determine NETs in the plasma of mice we used the following assay:
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Neutrophils generated by peritoneal lavage (see above) were induced to make NETs in vitro (see
below) by PMA stimulation overnight and NETs were scraped from the plate the following
morning. The samples were sonicated and the DNA content was measured using a picogreen
assay. The samples were then adjusted to 1 µg/ml as highest standard for the standard curve.
The curve was generated by 1:2 serial dilution of the top standard.
The biotinylated anti-NE antibody was coated onto the streptavidin coated plates supplied with
the Roche Cell Death Detection ELISA kit at 4°C overnight. The antibody was previously
diluted 1:100 and 50 µl were added per well. Coating was followed by washing three times with
PBS-T and blocking in 1 % BSA at room temperature for two hours. 50 µl of diluted standards
and samples were added afterwards and plates were incubated two hours at room temperature
with agitation at 350 rpm.
Plates were washed at least three times with PBS-T and 50µl of anti-DNA-POD antibody diluted
1:100 in its supplied dilution buffer was added to the plate for two hours at room temperature
and with agitation at 350 rpm. Plates were washed again and subsequently developed with ABTS
substrate supplied with the Cell Death Detection ELISA kit. Plates were stopped after sufficient
color change could be observed and measured in a microplate reader.
13.9.4 Cytokine measurement by Bio-plex assay
To simultaneously detect multiple cytokines in plasma samples that are restricted in volume
multiplex assays were performed in accordance with manufacturer’s instructions (BioRad).
Multiplex assays rely on a capture antibody coupled to differentially sized beads that can be
sorted according to cytokine they recognize. Cytokines are detected by biotinylated secondary
antibodies that bind streptavidin coupled to PE.
In brief the filter plate was washed, polystyrene beads added and the plate was washed again.
The 50 ml of plasma was added per well, the samples were diluted 1:4. After 30 minutes
incubation on a plate shakers the plate was washed, detection antibody added and the plate
incubated for 30 minutes while shaking. The plate was washed again and streptavidin-PE was
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added,  followed  by  a  15  minutes  incubation.  The  plate  was  then  washed  again,  beads
resuspended in assay buffer and measured on a Bio-Plex 200 system (BioRad).
13.10Immuno-/Histochemical assessment of mouse organs
The scoring of liver pathology as well as the counting of parasites sequestered to the
microvasculature of the livers was performed by trained pathologists at the iPATH-Berlin Core
Unit for immunopathology of experimental model organisms. The laboratory also performed
the sectioning of paraffin blocks and the staining necessary for the individual quantification.
13.11Immunofluorescence of Tissue Sections
The mouse tissue was fixed in 2% paraformaldehyde solution in Tris-buffered saline (TBS, pH
7.4) for 20 hours at room temperature. The tissue was then dehydrated and paraffin-embedded
(60°C) using a Leica TP 1020 tissue processor.
Paraffin blocks were cut to 3 μm and sections were mounted and dried on Superfrost Plus slides
(Thermo Scientific) avoiding temperatures above 37°C. After dewaxing and rehydration,
sections were incubated in HIER buffer pH6 (citrate buffer) [20 minutes at 96°C in a steam
cooker (Braun)].
After antigen retrieval, sections were left in the respective HIER buffer at room temperature to
cool below 30°C, rinsed with deionized water three times, PBS pH7.4 one time, and
permeabilized for five minutes with 0.5% Triton-X100 in PBS at room temperature, followed
by three rinsing steps with PBS.
Sections were surrounded with PAP-pen and treated with blocking buffer for 30 minutes  to
prevent non-specific binding. Primary antibodies were diluted in blocking buffer and incubated
on the sections over night at RT. We used secondary antibodies raised in donkey and pre-
absorbed against serum proteins from multiple host species (Jackson Immuno Research).
Dilution and blocking buffer was PBS supplemented with 1% BSA/2% donkey NS/5% cold
water fish gelatin/0.05% Tween 20/0.05%Triton X100.
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